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ABSTRACT
BINARY MIXTURES OF PYRETHROIDS INTERACT WITH VOLTAGESENSITIVE CALCIUM AND CHLORIDE CHANNELS IN ISOLATED
PRESYNAPTIC NERVE TERMINALS FROM RAT BRAIN
SEPTEMBER 2008
HILLIARY E. HODGDON
B.S., UNIVERSITY OF MASSACHUSETTS-AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS-AMHERST
Directed by: John M. Clark

Select pyrethroid binary mixtures (deltamethrin plus S-bioallethrin, β-cyfluthrin,
cypermethrin, and fenpropathrin) elicit a more-than-additive response on L-glutamate
release from rat brain synaptosomes that is independent of calcium influx. Using a
variety of chloride channel antagonists, anthracene-9-carboxylic acid (9-AC),
rChlorotoxin (ClTx), 4,4’-dintitrostilbene-2,2’-disulfonic acid (DNDS), 5-nitro-2-(3phenylpropylamino) benzoic acid (NPPB), and picrotoxinin (PTX), we have identified
two mechanisms by which pyrethroids may enhance L-glutamate release. The results
from this study indicate that only ClTx and NPPB, at their EC50s (0.1 µM and 70 µM,
respectively), significantly increase L-glutamate release when in the presence of our most
potent pyrethroid, deltamethrin, at its EC50 (2 x 10-12 M). When these two antagonists
were used in the presence of deltamethrin plus cypermethrin and deltamethrin plus
fenpropathrin, a more-than-additive response was elicited at lower concentrations of the
binary mixtures.

Likewise, NPPB in the presence of the additive binary mixture,

deltamethrin plus tefluthrin, first elicited a more-than-additive response at the 1:10

vi

mixture. Since both ClTx and NPPB are inhibitors of voltage-gated chloride channels
(ClC-2) and calcium-activated chloride channels, our findings suggest that these channels
are potential target sites for certain pyrethroids and likely are important in pyrethroid
neurotoxicity.
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CHAPTER 1

INTRODUCTION

1.1 Regulatory History of Pyrethroids

The United States Environmental Protection Agency (USEPA) regulates pesticides
under two major statutes: the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA) and the Federal Food, Drug, and Cosmetic Act (FFDCA). Under FIFRA, the
EPA is responsible for registering pesticides for use in the United States and prescribing
regulatory requirements to prevent unreasonable adverse effects on human health and the
environment while the FFDCA requires the EPA to establish tolerances for pesticide
residues in food (United States Environmental Protection Agency 2007c). In 1996,
Congress passed the Food Quality Protection Act (FQPA) that mandated the USEPA to
complete the review and reassessment of the tolerances (maximum legally permissible
levels) for all food use pesticides within a decade (United States Environmental
Protection Agency 2007c).
Since the enactment of the FQPA, many efforts have been made to update and
resolve inconsistencies between the two major pesticide statutes by establishing a more
consistent and protective regulatory scheme including, a mandate of a single, healthbased standard for all pesticides in all foods, an expansion of the scope of protection for
infants and children, and a reassessment of the safety of existing tolerances and tolerance
exemptions (United States Environmental Protection Agency 2007a).
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N-methyl carbamates and organophosphates are among the classes of pesticides
being reassessed under the FQPA for cumulative risk since some share a common
mechanism of toxicity (e.g., act the same way to produce toxicity). In conducting these
cumulative risk assessments, the EPA must evaluate the potential for a person to be
exposed to more than one compound from food, drinking water, and residential sources
(United States Environmental Protection Agency 2007b).
Thus far, findings from the cumulative risk assessments have led to the
discontinued or restricted use of certain pesticides from the carbamate and
organophosphate classes of insecticides (United States Environmental Protection Agency
2007a, United States Environmental Protection Agency 2006). It is expected that the use
of other control agents, specifically the pyrethroid insecticides, will increase in order to
ensure and maintain agricultural productivity and control of insect vectors of human and
animal diseases.
Pyrethroids account for approximately one quarter of the worldwide insecticide
market and have been used since the 1970s as control agents in urban areas and to control
insects that vector diseases such as malaria, dengue fever, and West Nile virus (Casida,
J.E. 1998; Narahashi, T. 1992; Trainer, V.L. 1997; Takken, W. 2002). Pyrethroids are
synthetic insecticides that were optimized based on the structures of the six naturallyoccurring pyrethrin esters of the pyrethrum extract derived from the flower heads of
Chrysanthemum cinerariaefolium (Soderlund, D.M. 2002). For almost two centuries,
pyrethrum was the most important botanical insecticide because of its potency and
selectivity to insects.

Pyrethrum, however, is highly susceptible to hydrolytic ester

cleavage and is unstable in light and air, greatly diminishing its effectiveness as a field
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stable insecticide (Casida, J.E. 1998; Soderlund, D.M. 2002).

The development of

synthetic pyrethroids was the result of efforts to increase their photostability and acute
neurotoxicity in insects by altering either the cyclopropanecarboxylic acid or
cyclopentenolone alcohol moieties of the pyrethrin esters (Fig. 1) (Soderlund, D.M.
2002). In fact, mammals are three orders of magnitude less sensitive to the toxic action
of pyrethroids than insects owing to their rapid metabolism, poor absorption, higher body
temperature (pyrethroids have a negative temperature coefficient of action), and lower
sensitivity of ion channel target sites (Clark, J.M. 1994; Narahashi, T. 1992; Soderlund,
D.M. 1989; Ray, D.E. 2006). Given the high risk of exposure due to the widespread use
of pyrethroids in agriculture and public health and the potential for their usage to
increase, the EPA must likewise consider the cumulative risk of pyrethroids in mammals
under the FQPA criteria.

Figure 1. The chemical structure of pyrethrin I, the most toxic ester of pyrethrum. This
structure is the basis for all pyrethroids (reproduced from Soderlund 2002).
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Overall, the entire molecular shape and stereospecificity of pyrethroids rather than
a specific substructure, reactive entity, or molecular moiety of the compound, are
responsible for pyrethroid toxicity (Elliott, M. et al. 1974; Soderlund, D.M. 200). The
acute neurotoxicity of pyrethroids has been well characterized and an initial classification
based on their symptomology in rats has been established (Verschoyle, R.D. 1980;
Shafer, T.J. 2005). Pyrethroids producing hypersensitivity, aggression, convulsions, and
fine tremor progressing to whole-body tremor were termed tremor (T) syndrome.
Pyrethroids producing pawing and burrowing, salivation, and coarse tremor progressing
to choreoathetosis (sinuous writhing convulsions) were termed choreoathetosis with
salivation (CS) syndrome (Verschoyle, R.D. and Barnes, J.M. 1972; Lawrence, L.J. 1982;
Gammon, D.W. 1981). An alternative nomenclature for pyrethroids was later proposed
based on their chemical structures and their toxicological effects produced in insects.
Pyrethroids containing an α-cyano-3-phenoxybenzyl alcohol group were called Type II
pyrethroids whereas compounds lacking an α-cyano group were called Type I pyrethroids
(Lawrence, L.J. 1982; Gammon, D.W. 1981). Although the Type I/II nomenclature has
been widely adopted in literature and is often used synonymously with the T/CS
syndrome terminology respectively, some pyrethroids exhibit an intermediate syndrome
composed of both T and CS syndromes, some Type I pyrethroids elicit the CS-syndrome
(permethrin), and some Type II pyrethroids elicit the T-syndrome (fenpropathrin)
(Verschoyle, R.D. 1980; Lawrence, L.J. 1982; Soderlund, D.M. 2002).
In the 1970s, Aldridge et al. demonstrated that the in vivo action of deltamethrin
(CS-syndrome pyrethroid) on the nervous system was different from that of cismethrin
(T-syndrome pyrethroid) and DDT. After treating rats orally with DDT, cismethrin, and
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deltamethrin, they found that deltamethrin caused a 52% decrease in acetylcholine
content of the brain and cerebellum whereas DDT and cismethrin caused no significant
reduction in the amount of neurotransmitter present (Aldridge, W.N. 1978). A more
recent study conducted on freely moving rats validated this in vivo finding and showed
that deltamethrin caused a concentration-dependent efflux of acetylcholine at the onset of
the CS symptomology (Hossain, M.M. 2004). Collectively, these findings suggested that
CS-syndrome pyrethroids act differently at the presynaptic nerve terminal than Tsyndrome pyrethroids. This difference may be responsible for the different neurotoxic
action of CS-syndrome pyrethroids versus T-syndrome pyrethroids (Ray, D.E. 1979).
Over the past three decades, voltage-gated sodium channels (VGSC) in nerve
axons have been well documented as a principal site of action of all pyrethroids in both
insects and mammals (Soderlund, D.M. 1989; Narahashi, T. 1992; Soderlund, D.M.
2000). Intracellular recordings of action potentials in nerve axons demonstrated that
pyrethroids produce two distinct types of effects on nerve excitability depending on the
structure of the pyrethroid. Type I poisoning is characterized by a slowing of VGSC
inactivation, resulting in a depolarizing after potential (DAP) due to an increase in “late
current”. The DAP results in the spontaneous firing in action potentials and ultimately
long trains of repetitive discharges, which are directly correlated to the tremors produced
by T-syndrome pyrethroids and are qualitatively similar, if not identical, to the actions of
the well established VGSC agonist, DDT (Narahashi, T. 1960; Lund, A.E. 1983;
Soderlund, D.M. 2000; Narahashi, T. 1992; Ray, D.E. 2006). Type II pyrethroids that
produce the CS-syndrome most noticeably slow the deactivation kinetics of VGSCs,
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resulting in a prolonged sodium tail current that eventually causes conduction block
(Shafer, T.J. 2005; Soderlund, D.M. 2002).
In addition to VGSCs, ATPases, L-glutamate receptors, acetylcholine receptors,
gamma aminobutyric acid (GABA) gated chloride channels, voltage-gated calcium
channels (VGCCs) and chloride channels (VGClCs) have been identified as potential
molecular targets of pyrethroid activity (Soderlund, D.M. 2002). Only the latter two
(VGCCs and VGClCs), however, are altered by relatively low concentrations of
pyrethroids, elicit stereospecific actions, and have been implicated in the acute
neurotoxicological response in functional assays (Hildebrand, M.E. 2004; Ray, D.E.
2000; Soderlund, D.M. 2002; Symington, S.B. 2007b).
Evidence for VGCCs as a site of action for pyrethroids at the presynaptic nerve
terminal

has

been

demonstrated

using

isolated

presynaptic

nerve

terminals

(synaptosomes) from rat brain (Symington, S.B. 2007b). Upon depolarization, both
cismethrin, a T-syndrome pyrethroid, and 1R-deltamethrin, a CS-syndrome pyrethroid,
resulted in a concentration-dependent increase in calcium influx whereas their inactive
stereoisomers, bioresmethrin and 1S-deltamethrin respectively, did not (Symington, S.B.
2007b). Furthermore, though both cismethrin and 1R-deltamethrin stimulated calcium
influx, only 1R-deltamethrin enhanced Ca2+-dependent neurotransmitter (L-glutamate)
release.

L-glutamate release was stimulated by K+ depolarization, unaltered by the

VGSC antagonist, tetrodotoxin, and blocked by ω-conotoxin GVIA, the N-type calcium
channel antagonist, implicating the N-type VGCCs as target sites for CS-syndrome
pyrethroids (Clark, J.M. 2007).
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The stereospecific

action

of pyrethroids

was

further validated

using

heterologously expressed CaV2.2 (N-type calcium channel from rat brain) in Xenopus
laevis oocytes.

Contrary to their findings in synaptosomes, Clark found that 1R-

deltamethrin reduced peak current in a concentration-dependent manner via wild-type
channels (T422) while the inactive stereoisomer, 1S-deltamethrin, had no effect. In a
permanently phosphorylated form of CaV2.2 (T422E mutant), however, peak current
increased in the presence of 1R-deltamethrin while 1S-deltamethrin had no significant
effect (Clark, J.M. 2007). The permanently unphosphorylated form of CaV2.2 (T422A),
unlike the wild-type and T422E channels, displayed a significant decrease in peak current
in the presence of both the deltamethrin stereoisomers (Symington, S.B. 2007a). Since
1R-deltamethrin was ~20-fold more potent on T422E CaV2.2 compared to wild-type,
T422 CaV2.2, the permanently phosphorylated form of CaV2.2 is assumed to be the
preferred target of deltamethrin. This contention is further supported by the observation
that protein phosphorylation patterns in synaptosomal preparations are modified by
deltamethrin, possibly by a Ca2+/diacylglycerol-dependent protein kinase (PKC)dependent pathway (PKC is the protein kinase that phosphorylates the T422 residue in
CaV2.2) (Matsumura, F. 1989; Zamponi, G.W. 1997; Enan, E. 1991; Clark, J.M 2008).
Thus, the differences in the action of deltamethrin on the functional synaptosomal
preparations versus the heterologously expressed CaV2.2 suggest that other regulatory
components modulating Ca2+ influx, including channel phosphorylation, may be
necessary to elicit an in vivo neurotoxic response (Symington, S.B. 2007a; Catterall,
W.A. 1997; Catterall, W.A. 1998).
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With respect to pyrethroids presenting a cumulative risk, it was shown that certain
binary mixtures of pyrethroids at their respective EC50s (equipotent binary mixtures)
resulted in a more-than-additive effect on neurotransmitter release that was not Ca2+
dependent (did not further modify VGCCs) (Table 1) (Frisbie, R.K. 2006).

These

mixtures included deltamethrin in binary combinations with S-bioallethrin, β-cyfluthrin,
cypermethrin, or fenpropathrin. This subgroup of pyrethroids does not fit cleanly into
either the neurotoxic syndrome (T- or CS- syndrome) or structural (Type I or II)
classifications. For example, fenpropathrin, a type II pyrethroid, elicits the T-syndrome.
This subset of pyrethroids, however, has been identified as calcium-independent VGClC
antagonists¸ implicating the importance of possible modification of VGClCs in the
neurotoxicological response of pyrethroids in mammals (Burr, S.A. 2004).
Originally, Forshaw et al. suggested that VGClCs were target sites for certain
pyrethroids using patch clamp electrophysiology. In mouse N1E-115 neuroblastoma
cells, low concentrations of 1R-deltamethrin, but not cismethrin, decreased the open
channel probability of voltage-gated maxi chloride channels. The deltamethrin effect
could be abolished with the addition of the chloride channel agonist pentobarbitone
(synonym: pentobarbital).

It was also found that pentobarbitone was effective at

reducing motor signs in rats caused by deltamethrin, but not the motor signs caused by
cismethrin (Forshaw, P.J. 1993; Forshaw, P.J. 2000). The authors speculated that the CSsyndrome produced by certain pyrethroids may be due to their antagonizing actions at
VGClCs.
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Table 1: Relationship of pyrethroids in binary mixtures on calcium influx and endogenous
L-glutamate released from rat brain synaptosomes.
Functional Assay Resultsa

Binary Mixtures
Calcium Influx

L-glutamate Release

α-Cyano + α-Cyano
Deltamethrinb,c + λ-Cyhalothrinb
Deltamethrin

b,c

Deltamethrin

b,c

Deltamethrin

b,c

Deltamethrin

b,c

Additive

Less-than-additive

b

Additive

Additive

b,c

Additive

More-than-additive

b

Additive

Additive

c

Less-than-additive

More-than-additive

-

More-than-additive

Less-than-additive

More-than-additive

Additive

Additive

Less-than-additive

Additive

Less-than-Additive

Additive

+ γ-Cyhalothrin
+ Cypermethrin

+ Esfenvalerate

+ Fenpropathrin

Deltamethrin b,c + β-Cyfluthrinb,c

α-Cyano + non-Cyano
Deltamethrin b,c + S-Bioallethrinc
Deltamethrin b,c + Permethrinb
Deltamethrin b,c + Tefluthrin

non-Cyano + non-Cyano
Permethrinb + S-Bioallethrinc
a

b
c

Indicates the functional relationship between pyrethroid binary mixtures determined
using the % additivity equation.
Pyrethroids in bold act as VGCC agonists.
Pyrethroids in italics act as VGClC antagonists as determined by Burr and Ray (Burr,
S.A. 2004).
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Burr et al. subsequently showed (Table 2) that bioallethrin (T-syndrome, type I),
β-cyfluthrin (CS-syndrome, type II), cypermethrin (CS-syndrome, type II), deltamethrin
(CS-syndrome, type II), and fenpropathrin (T-syndrome, type II), significantly decreased
open channel probability. Bifenthrin (T-syndrome, type I), bioresmethrin (T-syndrome,
type I), cispermethrin (T-syndrome, type I), cisresmethrin (syndrome not classified, type
I), cyfluthrin isomers 2 and 4 (T-syndrome, type I), λ-cyhalothrin (CS-syndrome, type II),
esfenvalerate (CS-syndrome, type II), and tefluthrin (T-syndrome, type I) did not
significantly alter open channel probability. Since esfenvalerate and λ-cyhalothrin were
both α-cyano and CS-syndrome pyrethroids and ineffective in decreasing open channel
probability, while fenpropathrin and bioallethrin, both T-syndrome and type II and I
pyrethroids, respectively, it was concluded that actions at the VGClC could not alone
account for the differences between the two types of poisoning syndromes and that there
were likely additional sites of action regulating the neurotoxicological response (Burr,
S.A. 2004). Table 2 summarizes the effects of Type I and II pyrethroids on decreasing
open channel probability of voltage-gated maxi chloride channels in excised inside-out
membrane patches from N1E-115 mouse neuroblastoma cells.

Pyrethroids were

considered to decrease the open channel probability of chloride channels if the open
channel probability significantly decreased post-dose as compared to pre-dose (Burr, S.A.
2004).
The GABA receptor-ionophore complex has likewise been implicated as a
molecular target contributing to the neurotoxicity of pyrethroids. Casida et al. initially
determined that certain pyrethroids also exhibit stereospecificity at the GABA chloride
channel (Casida, J.E. 1985; Lawrence, L.J. 1983).
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In radioligand [ 3 5 S] t-

Table 2: Comparison of type I and II pyrethroids on their effect of open channel
probability in voltage-gated maxi chloride channels.

Pyrethroid
(10 µM)

Type of
Pyrethroid

Syndrome
Elicited

Decreased Open
Channel Probability
(P < 0.05)

Deltamethrin

IIa,b,c,d

CSe

Yes

Cypermethrin

IIa,b,c

CSc

Yes

Fenpropathrin

IIa,d

Tf

Yes

β-cyfluthrin

IIb,d

CSb

Yes

Bioallethrin

Ia,b

Tf,g

Yes

Bifenthrin

Ib

Not Classifiedb

No

Cisresmethrin

Ia

Not Classified

No

Cyfluthrin isomer 2

II

CSh

No

Esfenvalerate

IIa,c,d

CSc,g

No

Cyfluthrin isomer 4

II

CSh

No

Tefluthrin

I

Th

No

λ-cyhalothrin

IIb,d

Th

No

Bioresmethrin

Ic

Tc

No

Cispermethrin

Ia,c

T

No

Note. Pyrethroids are ordered according to the significance of their effect as determined by their P value
(Burr, S.A. 2004).
a

(Gammon, D.W. 1982)
(Soderlund, D.M. 2002)
c
(Verschoyle, R.D. 1980)
d
(Wright, C.D.P. 1988)
e
(Barnes, J.M. 1974)
f
(Lawrence, L.J. 1982)
g
(Verschoyle, R.D. 1972)
h
(Symington, S.B. 2005)
b
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butylbicyclophosphorothionate ([35S]TBPS) binding studies using rat brain synaptic
membranes, only type II pyrethroids inhibited binding in a stereospecific manner by
binding to a site closely associated with that of TBPS and picrotoxin (both
noncompetitive GABAA receptor antagonists) within the chloride channel ionophore.
They determined that the toxic isomers of cypermethrin, deltamethrin, and fenpropathrin
(type II - cyanophenoxybenzyl esters), each at 5 µM, inhibited [35S]TBPS binding,
whereas pyrethroids (up to 10 µM) that lacked the α-cyano substituent, such as Sbioallethrin, did not inhibit [35S]TBPS binding.

Since no nontoxic stereoisomers

inhibited [35S]TBPS binding, it was suggested that the binding site in the receptor was
stereospecific to the chiral center found in toxic pyrethroids (Lawrence, L.J. 1983). It has
been shown subsequently that GABA receptor blockade is not nearly as sensitive to
pyrethroids as are VGSCs that are assayed in the same preparation.

Nevertheless, the

potential contribution of GABA receptors to the cumulative risk of pyrethroids cannot be
discredited (Soderlund, D.M. 2002).
Hossain et al. recently revealed that certain pyrethroids had differential effects on
glutamatergic (excitatory) and GABAergic (inhibitory) neurons in the hippocampus of
rats (Hossain, M.M. 2008).
Allethrin (type I) exhibited a dual effect where low doses resulted in an increase
in L-glutamate release but high doses of the compound decreased L-glutamate release.
Type II pyrethroids, cyhalothrin and deltamethrin, produced opposite effects.
Cyhalothrin inhibited L-glutamate release while deltamethrin increased L-glutamate
release, but in a dose-dependent manner.
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When GABAergic neurons were examined, extracellular levels of GABA
increased in the presence of allethrin at its high dose and cyhalothrin at all doses, but
decreased in the presence of deltamethrin. Interestingly, tetrodotoxin (TTX), a sodium
channel blocker, prevented the effect of allethrin and cyhalothrin at all doses on Lglutamate and GABA release, but only partially blocked the effects of the highest dose of
deltamethrin on L-glutamate release.

These findings suggested that the effect of

deltamethrin on L-glutamate release was not completely sodium-dependent and that
additional mechanisms of action at other ion channels may be responsible.

Local

infusion of the L-type calcium channel blocker, nimodipine, completely blocked
deltamethrin-evoked L-glutamate release at its highest concentration. These data
collectively suggest that the excitatory glutamatergic neurons in the hippocampus are
modulated by inhibitory GABA-releasing interneurons and confirm previous findings
that multiple mechanisms are likely involved with the neurotoxic action of pyrethroids
(Hossain, M.M. 2008).
In summary, certain binary mixtures of pyrethroids produce a more-than-additive
effect on L-glutamate release at presynaptic nerve terminals that is not calciumdependent.

In a separate study, all pyrethroids in the four more-than-additive binary

mixtures were also found to decrease the open channel probability of VGClCs,
suggesting that these channels may play a role in the more-than-additive response
previously observed in rat brain synaptosomes.

In addition, pyrethroids exhibit

stereospecificity at a binding site within the GABA chloride channel, the major regulator
of inhibitory neurotransmitter release, further establishing the role of chloride channels in
pyrethroid neurotoxicity. Thus, we hypothesize that an additional action at chloride
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channels may be responsible for the more-than-additive effect on L-glutamate release
previously seen with the equipotent binary mixtures of pyrethroids (deltamethrin with Sbioallethrin, β-cyfluthrin, cypermethrin, and fenpropathrin).

To test this hypothesis,

specific chloride channel blockers (antagonists) in the presence of deltamethrin were
expected to reproduce the more-than-additive response.
Synaptosomes are an ideal in vitro model system to use to study the effects of
pyrethroids since many of the physiological characteristics of the intact presynaptic nerve
terminal are retained including: K+ -stimulated Ca2+ influx and subsequent Ca2+ dependent endogenous neurotransmitter release (L-glutamate) (Symington, S.B. 2007b).
Additionally, synaptosomes are easily prepared, applicable to a variety of physiological
measurements using fluorescent spectrophotometry, and are fully functional for a period
of a few hours after preparation.
Since chloride channels generally function as rectifying channels to stabilize the
membrane potential (Clark, J.M. 1995), it is expected that blocking these channels in the
presynaptic nerve terminal, will increase neurotransmitter release. Furthermore, since
deltamethrin targets VGSCs, VGCCs, and VGClCs (Burr, S.A. 2004), it is expected that
deltamethrin at its EC50 value in the presence of a chloride channel antagonist will
reproduce the more-than-additive effect.

Lastly, concentrations of the four binary

mixtures of pyrethroids that produced more-than-additive effects on L-glutamate release
(Frisbie, R.K. 2006) should be shifted to lower concentrations in the presence of a
chloride channel antagonist. In the presence of a chloride channel agonist, the morethan-additive response should be shifted to higher concentrations.
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Antagonists and agonists were chosen based on their specificity to the many
different types of chloride channels found in presynaptic nerve terminals. Anthracene-9carboxylic acid (9-AC) and rChlorotoxin (ClTx) are VGClC and calcium-activated
chloride channel (CaClC) antagonists. 4,4' - dinitrostilbene - 2,2' - disulfonic acid
(DNDS) is a volume-regulated anion channel (VRAC) antagonist and 5-nitro-2-(3phenylpropylamino) benzoic acid (NPPB) is a VGClC, CaClC, and VRAC antagonist.
Picrotoxinin is an antagonist of the GABA-gated chloride channel while pentobarbital
and muscimol are GABA-gated chloride channel agonists.
Because there may be significant aspects of pyrethroid toxicity that were not
considered in their original evaluations, findings from these experiments are expected to
provide valuable insight into the assessment of the cumulative risk of pyrethroids and
therefore their regulation under the FQPA.

1.2 Voltage-Gated Calcium Channels

Of the many channels and pumps that control intracellular calcium levels,
voltage-gated calcium channels (VGCCs) play a key role in calcium homeostasis (PerezReyes, E. 2003). Depolarization-mediated calcium influx through VGCCs elicits a wide
range of cytoplasmic responses that includes contraction of cardiac muscle, cellular
proliferation, activation of calcium-dependent enzymes, and the release of hormones and
neurotransmitter molecules (Wheeler, D.B. 1994; Tedford, H.W. 2006; Evans, R.M.
2006). Several subtypes of VGCCs have been identified based on their pharmacological
and electrophysiological properties (termed L-, N- P-, Q-, R-, or T-types) with the
predominant diversity lying within the pore-forming α1 subunit (Evans, R.M. 2006).
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Although each subtype functions to allow the passage of calcium ions into
excitable cells, they differ in their cellular expression pattern, subcellular distribution, and
the cytoplasmic messenger molecules that regulate them (e.g. protein kinases and G
proteins) (Jarvis, S.E. 2001; Tedford, H.W. 2006). Calcium not only functions as a
second messenger, but its entry into the cell can cause depolarization and activate other
voltage-gated ion channels associated with the plasma membrane (Perez-Reyes, E. 2003).
Calcium entry into these cells is therefore carefully regulated since excessive amounts of
intracellular calcium are not only potentially toxic to the cell, but have also been linked to
several disorders, and mutations and deletions in voltage-gated calcium channel genes
have been associated with migraines, cerebellar ataxia, night blindness, and epilepsy
(Jarvis, S.E. 2001; Lorenzon, N.M. 2000).
There are three families of VGCCs classified by the α1 subunit gene subfamily (13). Calcium channels were named using the chemical symbol of calcium (Ca) with the
principal physiological regulator of this channel (voltage) indicated as a subscript (CaV)
(Catterall, W.A. 2003). Cav1 genes encode L-type channels, Cav2 genes encode N-type,
P/Q type, and R-type channels, and Cav3 genes encode T-type channels (Evans, R.M.
2006). Table 3 summarizes the physiological function and pharmacology of VGCCs.
For the purposes of this study, we focus on the Cav2 family of VGCCs, which are
responsible for calcium entry into neurons and for calcium-mediated neurotransmitter
release from presynaptic nerve terminals (Tedford, H.W. 2006).
The Cav2 subfamily (Cav2.1-3) includes channels containing α1A, α1B, and α1E
subunits, which allow P/Q-, N-, and R-type calcium currents, respectively. Alternative
splicing of the Cav2.1 gene gives rise to the P- and Q-type channels (Catterall, W.A.
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2000; Evans, R.M. 2006). Together the P/Q-type and N-type channels largely account
for the rapid release of synaptic vesicles at the presynaptic nerve terminal following
depolarization and calcium influx. The overall contribution of each, however, varies with
the neuronal preparation (Burke, S.P. 1993; Potier, B. 1993; Tedford, H.W. 2006). The
role of R-type channels is less well understood. They are localized to proximal dendrites
and presynaptic nerve terminals, and thought to also contribute to the synaptic release of
neurotransmitters (Tedford, H.W. 2006; Evans, R.M. 2006).
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Table 3: Voltage-gated calcium channel subunit compositions and functions (adapted from
Catterall 2003).
Ca2+ Channels

Ca2+ Current
type

Primary
Localizations

CaV1.1

L

Skeletal muscle

Excitation-contraction coupling
Calcium homeostasis
Gene regulation

CaV1.2

L

Cardiac muscle
Endocrine cells
Neurons

Excitation-contraction coupling
Hormone secretion
Gene regulation

CaV1.3

L

Endocrine cells
Neurons

Hormone secretion
Gene regulation

CaV1.4

L

Retina

Tonic neurotransmitter release

CaV2.1

P/Q

Nerve terminals
Dendrites

Neurotransmitter release
Dendritic Ca2+ transients

CaV2.2

N

Nerve terminals
Dendrites

Neurotransmitter release
Dendritic Ca2+ transients

CaV2.3

R

Cell bodies
Dendrites
Nerve terminals

Ca2+ -dependent action potentials
Neurotransmitter release
Repetitive firing

CaV3.1

T

Cardiac muscle
Skeletal muscle
Neurons

Repetitive firing

CaV3.2

T

Cardiac muscle
Neurons

Repetitive firing

CaV3.3

T

Neurons

Repetitive firing
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Cellular
Functions

1.3 Chloride Channels

Since the cloning and functional expression of the first member of the mammalian
voltage-dependent chloride channel (CLC) family of chloride channels in 1990 by
Jentsch et al, chloride channels have become one of the most exciting topics in channel
research.

It is now well established that these channels function in several critical

processes, including cell cycle and apoptosis, volume regulation, synaptic transmission,
and cellular excitability (Nilius, B. 2003). Chloride channels are classified according to
their mechanism of activation, and depends on: 1) transmembrane voltage (voltagegated/dependent/sensitive channels, the ClC family), 2) cell swelling (volume-regulated
anion channels, VRAC), 3) the binding of signaling molecules (ligand-gated anion
channels of presynaptic and postsynaptic membranes, such as glycine- or γ-aminobutyric
acid (GABA)- activated chloride channels, GABAClC), 4) the phosphorylation of
intracellular serine or threonine residues by protein kinases (cystic fibrosis
transmembrane conductance regulator, CFTR), and 5) various ions (e.g., anions, H+ (pH),
or Ca2+ (Ca2+- activated chloride channels, CaClC)) (Jentsch, T.J. 2002; Nilius, B. 2003).
This classification scheme is not perfect, however, as some mechanisms of activation
overlap (e.g. volume-regulated channels may also be voltage-dependent). It is likely that
the final classification will be based on structural classes once more is learned about the
structural similarities amongst channels (Jentsch, T.J. 1997).
There are currently three well-established gene families of chloride channels. In
mammals, these include the largest known family, the ligand-gated GABA and glycinereceptor chloride channels, the CFTR family, and the CLC family (Jentsch, T.J. 1997).
The plasma membrane of presynaptic nerve terminals possess ClCs, GABA/glycine-
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gated chloride channels, and the less well understood CaClCs (Meir, A. 1999) and hence
were the focus of this investigation.
The CLC has nine different genes in mammals that can be grouped into three
clades based on sequence homology (Fig. 2) (Jentsch, T.J. 1993).

The first clade

comprises plasma membrane channels ClC-1, ClC-2, ClC-Ka, and ClC-Kb, which are
close homologues of the prototype Torpedo marmorata channel ClC-0 and are involved
in the stabilization of membrane potential and transepithelial transport. Members of the
other two clades reside in intracellular membranes and have been implicated in the
acidification of intracellular compartments such as endosomes and lysosomes. These
include ClC-3, ClC-4, and ClC-5, and ClC-6 and ClC-7, respectively (Pusch, M. 2006;
Jentsch, T.J. 2005).
Although most channel proteins in the CLC family show voltage-dependent
gating, ClC-2 channels are highly expressed in specific regions of the brain and are
activated by hyperpolarized potentials, cell swelling, and acidic pH, all important features
of neuronal excitability (Thiemann, A. 1992; Grunder, S. 1992; Jordt, S.E. 1997).
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Expression

Function

ClC-1

Skeletal muscle

Stabilization of plasma membrane V

ClC-2

Broad

Transepithelial transport?
pH, volume regulation

ClC-Ka

Kidney, inner ear

Transepithelial transport

ClC-Kb

Kidney, inner ear

Transepithelial transport

ClC-3

Broad
(brain, kidney, liver…)

Acidification of endosomes, synaptic
vesicles

ClC-4

Broad (brain, muscle…)

?

ClC-5

Kidney (intestine, liver…)

Acidification of endosomes

ClC-6

Broad

?

ClC-7

Broad

Acidification of lysosomes, resorption
lacuna of osteoclasts.

ClC-0

Figure 2: The ClC family of chloride channels in mammals. The dendogram denotes the
similarity between the different genes. Distribution of genes in tissue and suggested
functions are indicated. Adapted from (Jentsch, T.J. 1997).

The ligand-gated ion channel (LGIC) superfamily also known as ionotropic
receptors, are regulated by the binding of chemical messengers, as opposed to the
voltage- or stretch-activated channels.

The LGIC superfamily is comprised of γ-

aminobutyric acid (GABA), glycine (GlyR), nicotinic acetylcholine (nAChR), and the 5hydroxytryptamine type 3 (5-HT3) receptors (Betz, H. 1990; Macdonald, R.L. 1994;
Kash, T.L. 2004).
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In the central nervous system (CNS), GABA modulates inhibitory synaptic
transmission by activating three classes of receptors: GABAA, GABAB, and GABAC
receptors. Of these, GABAA and GABAC belong to the LGIC family. GABAB receptors
belong to the G protein-coupled receptors (metabotropic receptors) (Meir, A. 1999). The
binding of GABA to the extracellular domain (ECD) causes a rapid allosteric transition in
the ion-conducting pore within the transmembrane domain (TMD) (Chakrapani, S. 2004).
The resulting chloride influx hyperpolarizes the neuron and inhibits neuronal activity
(Jentsch, T.J. 2002).
Chloride currents that are mediated by cytosolic calcium levels are termed
calcium-dependent or calcium-activated chloride channels (also known as CaCC, CaClC
or (Cl)Ca) (Hartzell, C. 2005). CaClCs have been identified in many cell types, including
epithelial cells, neurons, cardiac and smooth muscle cells, and blood cells (Eggermont, J.
2004; Hartzell, C. 2005). Likewise, they have been implicated in a variety of cellular
functions that include fertilization of oocytes, transepithelial fluid transport, and
membrane excitability in cardiac muscle and neurons (Hartzell, C. 2005). Although their
functions in neurons remain poorly established, it is thought that they are involved in
membrane repolarization, the generation of after-potentials, and membrane oscillatory
behavior (Hartzell, C. 2005). In most cells, the resting membrane potential is more
negative than the chloride equilibrium potential, so when intracellular calcium, ([Ca2+]i),
rises, chloride is effluxed from the cell causing a depolarization (Hartzell, C. 2005) and it
is thought that CaClC-induced depolarization may also activate VGCCs (Nilius, B.
2003).

Alternatively, if the chloride equilibrium potential is below the membrane
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potential, then opening of CaClCs can lead to hyperpolarization as chloride fluxes in
(Hartzell, C. 2005).
As their name implies, activation of CaClCs requires a rise in [Ca2+]i, which can
come from either intracellular stores or influx of extracellular calcium (Hartzell, C.
2005). In some cases, calcium channels are coupled to CaClCs, such as in mouse
sympathetic neurons, where L- and P-type VGCCs activate CaClCs (Martinez-Pinna, J.
2000). CaClC activation by calcium occurs via two general mechanisms: calcium can
either bind to the channel protein directly or act indirectly on the channel via Ca2+binding proteins (e.g. calmodulin) or Ca2+-dependent enzymes (e.g. calmodulindependent protein kinase of CamKII) (Hartzell, C. 2005).

1.4 Pharmacology of Chloride Channels

Ion channel modulators have important medical ramifications. Additionally, they
are also widely used to isolate ion channel proteins, to distinguish between gating states,
to investigate pore structure, and more commonly, to selectively suppress or enhance one
type of ion channel out of a mixture of currents. Unfortunately, this is often difficult to
do with anion channel modulators due to their inability to completely suppress ion flux.
Because of their low potency, the high concentrations utilized generally result in
undesirable side effects on ion transporters and components of intracellular signaling
pathways. Lastly, many anion channel blockers lack selectivity making interpretations
from pharmacological studies more complicated (Jentsch, T.J. 2002; Hartzell, C. 2005).

23

Table 4 provides the pharmacology profiles of the mammalian neuronal chloride
channels examined in this study. As mentioned previously, many chloride channels
overlap in their mechanisms of activation, and are likewise affected by a variety of
nonspecific modulators.

Table 4. Pharmacology of mammalian chloride channels in nerve preparations.
Inhibitor Type

Inhibitor

ClC-2

CaCC

Anthracene carboxylates

9-AC

√a,b

√d

Arylaminobenzoates

NPPB

√a,b,c

√e,f

Disulfonic stilbene

DNDS

Protein toxin

ClTx

Polycyclic epoxylactone

PTX

VRAC

GABAA ClC

√g
√g

√c

√f
√h

a

(Furukawa, T. 1998)
(Clark, S. 1998)
c
(Thompson, C.H. 2005)
d
(De Castro, F. 1997)
e
(Hartzell, C. 2005)
f
(Dalton, S. 2003)
g
(Abdullaev, I.F. 2006)
h
(Zhang, S.J. 1993)
b

1.5 Role of Chloride Channels in Neurotransmitter Release

Chloride is the most abundant extracellular physiological anion in animal cells
and plays a major role in stabilizing the membrane potential of excitable cells. In nerve
terminals, this stabilizing function of chloride channels is involved with the inhibition of
neurotransmitter release (Meir, A. 1999).

Since the concentration of chloride in the

cytoplasm is lower than outside of the cell, the chloride equilibrium potential (ECl) is
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generally close to the resting membrane potential (Grunder, S. 1992; Smith, R.L. 1995;
Meir, A. 1999).
Upon excitation of the membrane by depolarization due to sodium and/or calcium
influx, chloride channels oppose neuronal excitability by rectifying or repolarizing the
membrane potential by fluxing chloride ions into the cell, thus preventing the further
release of neurotransmitters (Hille, B. 2001; Suzuki, M. 2006). VGClCs are largely
responsible for rectifying the excitable membrane potential. ClC-2 in particular are
activated by hyperpolarization, deactivated by depolarization, and show no timedependent inactivation (Staley, K. 1994; Smith, R.L. 1995).
Fast inhibitory neurotransmission in the mammalian nervous system is mediated
by the neurotransmitter GABA.

In presynaptic nerve terminals, GABA-mediated

chloride current is believed to inhibit neurotransmitter release via two mechanisms. The
first is by retardation in the propagation of action potentials onto the nerve terminal, and
second, by a decrease in the amount of neurotransmitter released by each action potential
that reaches the terminal. This inhibition occurs by shunting membrane currents and
reducing the probability of other ion channels (sodium and calcium) opening (Jackson,
M.B. 1995; Meir, A. 1999). Another mechanism by which chloride channels regulate
presynaptic inhibition has been proposed by a mathematical model that suggests
depolarization, in association with an increase in outward chloride conductance, may
inactivate other ion channels in the nerve terminal such as calcium and sodium channels
(Graham, B. 1994).
CaClCs have also been implicated in the regulation of neurotransmitter release.
Although CaClCs are expressed in a variety of different neurons, their functions remain
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poorly established (Hartzell, C. 2005). Thus far, it is believed that CaClCs modulate
excitability by generating afterpotentials, which in some neurons, may be sufficient to
trigger spontaneous firing. It has been established that there are three factors that dictate
the direction of chloride through CaClCs: the membrane potential, chloride concentration
gradient, and the intracellular calcium concentration. When intracellular calcium
increases either due to release from intracellular stores or influx via VGCCs, CaClCs are
activated and cause chloride to exit the cell, resulting in a depolarization.

This

depolarization can increase the open channel probability of VGCCs resulting in
additional calcium influx, thus further enhancing the depolarization, and ultimately
neurotransmitter release. CaClCs can also lead to hyperpolarization when the membrane
potential is more positive than the ECl (Hartzell, C. 2005). See section 1.7 for regulation
of chloride channels.

1.6 Regulation of Chloride Channels

Given the ubiquitous expression and numerous physiological functions that
chloride channels possess, it is no surprise that they are likewise regulated or activated by
many mechanisms.

As previously mentioned in section 1.3, chloride channels are

classified according to their mechanism of activation. For the purposes of this study, the
mechanisms of activation for ClC-2, GABA ClCs, and CaClCs found in presynaptic
nerve terminals will be discussed.
ClC-2 belong to the family of voltage-gated chloride channels.

Since many

VGClCs function to rectify the membrane potential, the intracellular concentration of
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chloride is always lower than the extracellular concentration and ECl is still above the
resting membrane potential (RMP) (Hille, B. 2001). These channels would be expected,
when activated by hyperpolarization, to be inwardly rectifying with significant
conductance (GCl(v)) only at membrane potentials more negative than ECl, ultimately
repolarizing the cell during an action potential and reducing excitability (Staley, K. 1994;
Smith, R.L. 1995). In nerve terminals, the activation of VGClCs is associated with
presynaptic inhibition since the decreased efficiency of subsequent inward currents to
produce a depolarization reduces neurotransmitter release (Rudomin, P. 1990; Meir, A.
1999). It was determined that ClC-2 cDNA cloned from rat brain and heterologously
expressed in Xenopus laevis oocytes displayed a similar voltage dependence to GCl(v) and
that both ClC-2 and GCl(v) slowly activate at hyperpolarized potentials (-90 mV),
deactivate at depolarized potentials (-30 mV), and show no time-dependent inactivation
(Thiemann, A. 1992; Grunder, S. 1992; Staley, K. 1994).
Phosphorylation of ClC-2 channels suggests another possible mechanism by
which these channels are regulated.

One group showed that PKA was able to

phosphorylate ClC-2 in vivo and in vitro, but when heterologously expressed in Xenopus,
they found that the current was not affected (Park, K. 2001). To determine if PKA was
directly phosphorylating ClC-2 or doing so by acting through another kinase, PKC and
CaMKII were examined for their ability to phosphorylate ClC-2. Their findings revealed
that PKC (in vivo and in vitro) and CaMKII (in vitro) failed to phosphorylate ClC-2.
Though these results suggest that PKA activation of rat ClC-2 in vivo is independent of
chloride channel activity, the possibility that PKC or CamKII activation might indirectly
regulate ClC-2 activity cannot be ruled out (Park, K. 2001). A mechanism by which PKC
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may indirectly modulate ClC-2 activity is described by Hartzell et al. where an increase
in intracellular calcium due to IP3 activates CaClCs, which produces a depolarization and
ultimately feeds back to open additional ClC-2 (Hartzell, C. 2005).

Indirect

phosphorylation of ClC-2 by CaMKII has not been elucidated in rat neuron preparations,
but has been in other species and preparations (Hartzell, C. 2005). In another study,
researchers showed that rat ClC-2 lacked consensus sites for cAMP-dependent
phosphorylation, but rabbit and human ClC-2 (at different positions) had them (Jordt,
S.E. 1997). Together, these findings suggest that regulation of ClC-2 may be cell-type or
species-specific.
ClC-2 channels may also function to prevent excessive osmotic swelling. When
cells are exposed to hypotonic solutions or intracellular hypertonic solutions, they begin
to swell and then recover their normal volume by releasing enough salt to prevent further
water entry (Hille, B. 2001; Grunder, S. 1992; Nilius, B. 1996). It is said that during cell
swelling, depolarization due to the activation of this channel may also trigger exocytosis
in cells that possess L-type calcium channels (Grunder, S. 1992). However, these events
are likely not relevant to pyrethroid neurotoxicity since membrane depolarization and
increased neurotransmitter release from isolated presynaptic nerve terminals is observed
when these channels are blocked. The regulation of these channels by volume will
therefore not be further discussed.
It has been shown that the voltage-dependent current via ClC-2 is enhanced at
normal resting potentials by low extracellular pH (Jordt, S.E. 1997; Park, K. 2001). Also,
a deceleration in exocytosis was observed when chloride entry into chromaffin granules
was inhibited by NPPB, thereby impairing the acidification of the granule (Camacho, M.
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2006). Since neither of these events are consistent with previous findings that suggest
inhibition of chloride channels results in an increase in L-glutamate release from isolated
presynaptic nerve terminals, the regulation of ClC-2 by pH will not be discussed further
for its role in pyrethroid neurotoxicity and neurotransmission.
The GABA receptor chloride ionophore (GABAAClC) is a ligand-gated ion
channel superfamily, is responsible for fast inhibitory neurotransmission in the
mammalian nervous system. Binding leads to the opening of the chloride channel within
the complex and chloride influx, ultimately hyperpolarizing the neuron and thereby
inhibiting neuronal activity (Meir, A. 1999; Jentsch, T.J. 2002). It is also thought that
activation of ClC-2 may help the ligand-gated chloride channels to yield hyperpolarizing
currents since ClC-2 activity determines intracellular Na+ and Cl- concentration
(Dinudom, A. 1993; Suzuki, M. 2006).
GABAA receptors are also modulated by phosphorylation. Porter et al. found that
the GABAA receptor contains a consensus phosphorylation site on an intracellular
domain of the channel for cAMP-dependent protein kinase (PKA). Using whole-cell and
excised, outside out patch clamp on cultured mouse spinal neurons, PKA significantly
reduced GABA-evoked chloride currents by reducing the channel opening frequency and
they speculate that a reduction in receptor function may lead to increased neuronal
excitability (Porter, N.M. 1990). These findings are consistent with previous studies on
rat brain synaptoneurosomes where cAMP (an activator of PKA) decreased GABAA
receptor-mediated chloride flux (Heuschneider, G. 1989).
Browning et al. determined that Ca2+/phosphatidylserine-dependent protein kinase
(PKC) and PKA also phosphorylate the GABAA receptor purified from rat brain, but
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Ca2+/calmodulin kinase II (CaM kinase II) does not (Browning, M.D. 1990). Shortly
after these findings, another group found that the PKC activator, phorbol myristoyl
acetate (PMA), but not the inactive analog, phorbol 12-mono-myristate (PMM), inhibited
GABA-gated chloride currents in Xenopus oocytes expressing mouse brain mRNA
(Leidenheimer, N.J. 1992). They also found that PMA inhibited GABA-gated chloride
currents from GABAA receptors in oocytes coexpressing human α1β1γ2L subunit cDNAs.
In mouse brain microsacs, activators of PKC as well as inhibitors of protein
phosphatases, reduced muscimol-stimulated
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Cl- uptake by brain membrane vesicles

(Leidenheimer, N.J. 1992). In all, these findings provide evidence that the function of
GABAA receptors in situ can be inhibited by PKC phosphorylation.
CaClC activation requires a rise in intracellular calcium concentration ([Ca2+]i)
which can come from calcium influx or calcium release from intracellular stores. When
([Ca2+]i is below ~1 µM, calcium-activated chloride current (ICl,Ca) is both voltage and
time dependent, however, when ([Ca2+]i rises above ~1 µM, the voltage and time
dependence disappears as the activation rate increases. Deactivation of CaClCs follows a
time course that is voltage dependent (Hartzell, C. 2005).
Calcium can directly activate CaClCs by binding to the channel or indirectly
activate the channel by interacting with calcium-binding proteins or calcium-dependent
enzymes (Hartzell, C. 2005). One study using Xenopus oocytes injected with rat brain
mRNA, showed that L-glutamate receptors indirectly regulated calcium-dependent
chloride channels via an inositol 1,4,5-triphosphate (IP3)-Ca2+ pathway.

When L-

glutamate was applied to the bath, whole-cell currents were evoked and reversed
direction near the chloride equilibrium potential. Likewise, injection of IP3 or calcium
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into the oocyte caused an increase in intracellular free calcium regardless of extracellular
calcium and the subsequent current exhibited a reversal potential near the chloride
equilibrium potential.

These results suggested that glutamate receptors activate

endogenous chloride channels utilizing IP3 which mobilizes the calcium in the cell that
activates CaClCs (Oosawa, Y. 1989).
Additional evidence for activation of CaClCs by extracellular calcium was
demonstrated by Martinez-Pinna et al. when the use of selective VGCC inhibitors
revealed that L- and P-type VGCCs appear to selectively couple to CaClCs while N-type
VGCCs couple with calcium-activated potassium channels (Martinez-Pinna, J. 2000;
Hartzell, C. 2005).
To our knowledge, direct binding of calcium to CaClCs has not yet been reported
in neuronal preparations.

1.7 Role of Chloride Channels in Pyrethroid Neurotoxicity

VGSCs have been well established for decades as a major target site for all
pyrethroids, however, due to the variablity of pyrethroid structures and/or the bimodal
effect of pyrethroids on mammals (T- vs CS-syndrome), it was suggested that there was
either heterogeneity within the sodium channel targets (Soderlund, D.M. 2002) or that
pyrethoids, specifically the type II pyrethroids, had additional sites of action (Burr, S.A.
2004). Among the different sites of action proposed, chloride ion channels are believed
to contribute significantly to pyrethroid neurotoxicity. The first interaction of pyrethroids
on ligand-gated chloride channels was reported by Leeb-Lundberg and Olsen in 1980.
These findings established a stereospecific inhibition by deltamethrin on the binding of
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[3H]dihydropicrotoxinin to the convulsant site (chloride channel) of GABA receptors in
rat brain synaptic membranes (Leeb-Lundberg, F. 1980). Later Lawrence and Casida
conducted a study on 37 pyrethroids and documented the inhibition of [35S]TBPS binding
in rat brain synaptic membranes by the toxic isomers containing the α-cyano moiety, but
not by the non-toxic isomers of the α-cyano compounds or by any pyrethroids lacking the
α-cyano moiety (Lawrence, L.J. 1983). Gammon et al. likewise proposed that ligandgated chloride channels were targets in both mouse and cockroach preparations
(Gammon, D.W. 1982).
Collectively, these findings led to the hypothesis that type II pyrethroids were
convulsants and caused the CS-syndrome by blocking GABA binding at the GABA
receptor-ionophore complex and indirectly augmented the release of excitatory
neurotransmitters due to the reduced inhibitory input to the nervous system. Several
studies of α-cyano pyrethroids inhibiting GABA-stimulated chloride uptake into brain
vesicles further confirmed these pyrethroids as antagonists at the mamamalian brain
GABA receptors (Bloomquist, J.R. 1986; Abalis, I.M. 1986). However, chloride uptake
was typically incomplete at maximally effective pyrethroid concentrations. In addition,
electrophysiolgoical assays that assessed the relative sensitivity of GABA receptors and
VSSCs in dorsal root ganglion neurons found that GABA receptors were much less
senstive to the actions of deltamethrin than were VSSCs. In all, these findings indicated
that the ligand-gated chloride channel was not sufficiently sensitive to pyrethroids to have
an influence at doses relevant to systemic poisoning.
Not long after these findings, VGClCs were proposed as targets for pyrethroids
when it was found that deltamethrin decreased the open channel probability of these

32

channels, which was similar to the action of the chloride channel antagonist, 9-AC, in
excised, inside-out patches of N1E-115 neuroblastoma cells (Forshaw, P.J. 1993).
Additional studies further confirmed VGClCs as an improtant site of action for certain
type II pyrethroids in that deltamethrin and cypermethrin (type II pyrethroids) decreased
the open channel probability of VGClCs, while the type I pyrethroid cismethrin did not
(Ray, D.E. 1997).

Interestingly, the chloride channel agonist, pentobarbitone, was

effective against the type II motor signs caused by deltamethrin, but not against the type I
motor signs produced by cismethrin (Forshaw, P.J. 2000). Since deltamethrin affected
VGClCs at concentrations that were toxicologically relevant, it was proposed that type II
pyrethroids may contribute to the bimodal nature of the pyrethroid poisoning syndromes.
These effects of pyrethroids on these channels, however, have not been confirmed in
insect preparations (Bloomquist, J.R. 2003).
To date, CaClCs have not been implicated in the acute neurotoxic action of
pyrethroids in either mammalian or insect preparations.

However, the existence of

pharmacological crosstalk between different chloride channel types complicates the
pharmacological discrimination between these channels, and thus, they cannot be
overlooked for their contribution to pyrethroid neurotoxicity (Soderlund, D.M. 2002)

.
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CHAPTER 2

MATERIALS AND METHODS

2.1 Animals

Retired (ex-breeder) female Sprague-Dawley rats (400-600 g and ≥ 8 months)
were purchased from Charles River Laboratories (Wilmington, MA) and maintained at
the Central Animal Care Facility, Morrill Science Center 4 South, University of
Massachusetts-Amherst (Amherst, MA).

Animals were accommodated in standard

plastic animal cages (45 cm x 24 cm x 20 cm) at two per cage ad libitum, on a 12:12 hr
day and night light cycle. Animal procedures were conducted in accordance with the
Institutional Animal Care and Use Committee (IACUC) guidelines (Protocol #: 26-0912).

2.2 Chloride Channel Ligands

Chloride channel blockers (antagonists); anthracene-9-carboxylic acid (9-AC),
4,4’-dintitrostilbene-2,2’-disulfonic

acid

(DNDS),

5-nitro-2-(3-phenylpropylamino)

benzoic acid (NPPB), and picrotoxinin (PTX) were purchased from Sigma-Aldrich Inc.
(St. Louis, MO) and rChlorotoxin (ClTx) was purchased from Alomone labs (Jerusalem,
Israel). Stock solutions of 9-AC, DNDS, and NPPB were made in dimethyl sulfoxide
(DMSO) with the final serial dilutions in 95 % ethanol. All PTX stock solutions were
solubilized in 95% ethanol. ClTx was made in a conventional buffer of 20 mM HEPES
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(pH 7.0). New stock solutions were made monthly and stored at -20 oC. See Appendix A
for the chemical structures of the chloride channel ligands used in this study.

2.3 Pyrethroids

Technical grade pyrethroids (Table 5) used in this study were provided by the
Pyrethroid Working Group (PWG); a conglomerate of the major manufacturers of
synthetic pyrethroids in the United States and United Kingdom that is comprised of
Aventis CropScience (Dublin, NJ), Bayer Corporation (Kansas City, MO), DuPont
Agricultural Products (Newark, NJ), FMC Corporation (Philadelphia, PA), Syngenta
(Cheshire, UK) and Valent USA Corporation (Montvale, CA).
Pyrethroid stock solutions were prepared in DMSO and serial diluted as required.
The final serial dilution was made in 95 % ethanol. Binary mixtures of pyrethroids were
prepared in equipotent ratios of their respective EC50s the day of experiments unless
otherwise indicated. See Appendix B for the chemical structures of the pyrethroids used
in this study.
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Table 5. The isomeric composition of the pyrethroids used in this study.
Compound Name
(Manufacturer)

CAS RN

Isomeric Composition

Cypermethrina (FMC)
(S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2dichlorovinyl)-2,2-

52315-07-8

98.7%(S)-α-cyano-, (1R)-cis-

dimethylcyclopropanecarboxylate

Deltamethrina (Aventis)
(S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2dibromovinyl)-2,2-

52820-00-5

98.0%(S)-α-cyano-, (1R)-cis-

dimethylcyclopropanecarboxylate

Fenpropathrina (Valent)
(RS)-α-cyano-3-phenoxybenzyl 2,2,3,3-

64257-84-7

tetramethylcyclopropanecarboxylate

99.7%(RS)-α-cyano-

Tefluthrina (Syngenta)
2,3,5,6-tetrafluoro-4-methylbenzyl (Z)(1R,3R)-3-(2-chloro-3,3,3-trifluoroprop-1-

79538-32-2

95.0%(Z)-(1R)-cis-

enyl)-2,2-dimethylcyclopropanecarboxylate
a

Structures for pyrethroids used in this study are illustrated in Appendix B.
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2.4 Chemicals

Percoll™ was purchased from GE Healthcare Bio-Sciences Corporation
(Piscataway, NJ).

Amplex® UltraRed reagent was purchased from Invitrogen

Corporation (Carlsbad, California). All other chemicals and enzymes were purchased
from Sigma-Aldrich Inc. (St. Louis, MO) at the highest purity available.

2.5 Synaptosome Preparation

Synaptosomes were prepared from whole rat brain sans brain stem as previously
described (Dunkley et al., 1986) with the following modifications. Rats were sacrificed
by decapitation after CO2-induced unconsciousness and whole brains removed. Brain
tissue was homogenized using a 15 ml Teflon-glass homogenizer with a motor-driven
pestle (Model K43, Tri-R Instruments, Rockville Centre, NY) for 4-5 cycles at 400 rpm
(~2-3 min) in ice-cold sucrose buffer (0.32 M sucrose, 1 mM EDTA, and 5 mM tris-base,
pH = 7.4) and the homogenate centrifuged at 900 g for 10 min at 4 °C. The supernatant
was transferred and divided into two new tubes and centrifuged at 15,000 g for 30 min at
4 °C. The resulting crude mitochondrial pellets (P2) were gently resuspended manually
in saline A buffer (125 mM NaCl, 5 mM KCl, 1.2 mM NaH2PO4, 1.2 mM MgCl2, 5 mM
NaHCO3, 20 mM HEPES, pH = 7.4) with 10 mM glucose using a 5 ml Teflon-glass
homogenizer. The P2 suspensions were transferred to the top of a discontinuous Percoll™
gradient (4%, 10%, 15%, and 23% Percoll™ in ice-cold sucrose buffer, pH = 7.4) and
centrifuged at 32,500 g for 10 min at 4 °C. Of the 5 bands formed between the sucrosepercoll layers in the gradient, bands 3 and 4 (containing the purified synaptosomes), were
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collected by aspiration and placed into 2 new tubes filled with saline A buffer containing
glucose.

After mixing, the washed synaptosomes were collected by centrifuging at

15,000 g for 10 min at 4 °C.

The supernatant was decanted and the purified

synaptosomal pellets were resuspended manually using a 5 ml Teflon-glass homogenizer
into a total of ~4 ml saline A with glucose.

2.6 Synaptosome Protein Determination

Synaptosomal protein concentration was determined spectrophotometrically using
the bicinchoninic acid (BCA) assay (Smith et al., 1985). Protein induced color changes
were measured with a UVMAX kinetic microplate spectrophotometer at λ = 560 nm
(Molecular Devices, Sunnyvale, CA). Protein concentrations were extrapolated from a
standard curve using bovine serum albumin (BSA) as the standard protein. The standard
curve was constructed by plotting absorbance (O.D.) as a function of the amount of BSA
and synaptosomal protein values were estimated from the linear regression of the data
generated from the standards.

2.7 Neurotransmitter Release Assay

Endogenous neurotransmitter release from synaptosomes was determined using
an enzyme-linked assay with Amplex® UltraRed for the detection of L-glutamate as
previously described (Nicholls, D.G. 1987; Symington, S.B. 2005).

Purified

synaptosomes were diluted in saline A buffer with glucose to a final protein
concentration of 2 mg/ml and incubated with the appropriate pretreatments (antagonists)
and treatments (pyrethroids). Solvent concentration during the addition of an antagonist
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did not 0.2% DMSO/ethanol or 1% water when added to synaptosomes for pretreatment
(5 min at 37 oC). Pretreatments were followed by treatment with 0.2 µl of a 1000-fold
concentrated stock solution of each pyrethroid binary mixture in DMSO or DMSO alone
as a solvent control (99.9 % DMSO for a total DMSO concentration of 0.2%) for 20 min
at 37 oC prior to the start of each assay. Treated synaptosomes were added to 1.4 ml of
warmed (37 oC) saline B buffer with 10 mM glucose (2 mM CaCl2, 125 mM NaCl, 5 mM
KCl, 1.2 mM MgCl2, 20 mM HEPES, pH = 7.4) containing 50 µM Amplex®, 0.04 U/ml
glutamate oxidase, and 0.125 U/ml horseradish peroxidase and aliquoted (150 µl/well) to
a 96-well microtiter plate.

The plate was mixed for 5 sec and basal fluorescence

monitored (0-2 min) (Exλ = 530 nm and Emλ = 591 nm) at 37 °C using a Gemini-XS
SPECTRAmax® fluorescent microplate reader (Molecular Devices, Sunnyvale, CA)
equipped with SOFTmax® Pro software, Version 3.1.2 for Windows-PC (Molecular
Devices). Synaptosomes were subsequently depolarized by adding 5 µl aliquots of KCl
stock solutions (4, 8, 20, 40, or 60 mM final assay KCl concentration) and the net
increase in the amount of L-glutamate released was determined from fluorescence
recordings at 30 min post-depolarization. The 30 min incubation ensures quantitative
detection of L-glutamate released (Invitrogen Product Information A12221) that occurs
during the first ~10 s of depolarization (Wennemuth, G. 2000).
The total L-glutamate content of synaptosomes was determined using the
nonionic detergent, 0.5% Triton X-100. Percent L-glutamate release was then calculated
as indicated by Equation 1 (Symington, S.B. 2007b).
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Equation 1

Percent Glutamate Released =
 Glutamate released after depolarization - L - Glutamate released before depolarization 

 x 100
Total
glutamate
content
of
synaptosom
es



Values for endogenous neurotransmitter (L-glutamate) released were extrapolated
from a standard curve.

The L-glutamate standard curve was set up exactly as the

neurotransmitter release assay, except in the absence of synaptosomes. Serial dilutions of
L-glutamate (0-450 pmoles) were added (5 µl/well) in place of synaptosomes to a 96-well
microtiter plate and fluorescence monitored as above. A standard curve was constructed
by plotting the relative fluorescence units (RFU) generated as a function of the amount of
L-glutamate present.

2.8 Assessment of the Effects of Antagonists and Pyrethroids

The data were first fit to a linear regression (Equation 2) using GraphPad Prism
Software (Version 3.02, GraphPad Inc., San Diego, CA) to determine if the relationship
between increasing concentration of the antagonist and the effect on L-glutamate release
had a slope that was significantly different from zero. Slopes that were not significantly
different from zero as determined by Equation 2 were not further evaluated for a
concentration-dependent response. If the slope was significantly different from zero, the
data were fit to the polynomial first order (Equation 2) and the sigmoidal dose-response
(variable slope) equation (Equation 3) using GraphPad Prism Software (Version 3.02,
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GraphPad Inc., San Diego, CA), and compared with an F-test to determine which
equation fit the data best. Data that best fit Equation 2 were considered non-sigmoidal
and EC50 values not determined. Data that best fit Equation 3 displayed a concentrationdependent response and EC50 values were determined.
Pyrethroid EC50 values were determined from concentration-dependent response
curves previously generated by Frisbie (Frisbie, R.K. 2006). These data were used to
establish a potency ratio that equalizes the potency of each antagonist and pyrethroid
used in the generation of each binary mixture.

Equation 2

y = mx + b

Where:
y = Independent variable of the function x.
m = Slope of the line.
b = Y-intercept of the line.
x = Independent variable of the function y.

Equation 3

Response = β 0 + (β max - β 0 ) / (1 + 10(log EC50 - X)(Hill Slope) )
Where:

β0= 0 (Constant).
βmax = Efficacy Value.
EC50 = Potency Value, effective concentration producing 50% maximal response.
Hill Slope = Slope of the concentration-response curves and describes binding
characteristics. If the Hill Slope is far from 1, receptor-ligand binding does not follow the
law of mass action for a single site of action, but suggests multiple binding sites. A
positive (+) Hill Slope suggests cooperative receptor-ligand interaction and a negative (-)
Hill slope suggests noncooperative receptor-ligand interaction.
X = Log concentration of pyrethroid.
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Antagonist and pyrethroid interactions on L-glutamate release were assessed by
measuring the percent additivity (% additivity), which provides an efficacy measurement
of interactions in binary mixtures (Equation 4) as described (Martin et al., 2003) with the
following modifications (Frisbie, R.K. 2006).
Actual response values obtained for each binary mixture were compared to the
theoretical response values to determine an additive, more-than-additive, or less-thanadditive relationship between pyrethroids or toxin and pyrethroid binary mixtures
(Frisbie, R.K. 2006).

Equation 4
 Actual Response - Theoretica l Response 
a
b
 x 100
% More or Less Additivit yC= 
Theoretica l Response



Where:
Theoretical Response = Assay response value of a toxin at its EC50 added to the assay
response value of a pyrethroid at its EC50 or pyrethroid 1 at its EC50 added to the assay
response value of pyrethroid 2 at its EC50.
Actual Response = Assay response value of the binary mixture at each component’s
EC50.
a

A positive percent additivity value indicates a more than additive response.
A negative percent additivity value indicates a less than additive response.
c
A value of 0 indicates additive response.
b
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2.9 Statistical Analysis of Data

Unless otherwise stated, mean values (± S.E.) for L-glutamate release were
determined from at least three synaptosome preparations using the average values
obtained from eight replicates per synaptosome preparation (n ≥ 3).

Statistical

significance of L-glutamate released due to treatment was assessed by the unpaired t-test
(GraphPad Prism Version 3.02) using P < 0.05 as a criterion for evaluation.

For

antagonist and binary mixture evaluations, statistically significant differences in Lglutamate release were assessed using unpaired t-tests (GraphPad Prism Version 3.02) at
P < 0.05. A one-way ANOVA using Tukey’s multiple comparison post-test was used to
compare all possible combinations of treatments and determine statistical significance of
L-glutamate released (GraphPad Prism Version 3.02) using P < 0.05 as a criterion for
evaluation.
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CHAPTER 3

EFFECTS OF SELECTED CHLORIDE CHANNEL ANTAGONISTS ON
PYRETHROID-ENHANCED NEUROTRANSMITTER RELEASE FROM
SYNAPTOSOMES

3.1 Effect of Chloride Channel Antagonists on L-Glutamate Release

Rat brain synaptosomes, depolarized with 20 mM KCl, were used to evaluate the
effects of selected chloride channel antagonists on L-glutamate release in equipotent
binary mixtures with either cypermethrin, deltamethrin, fenpropathrin or tefluthrin to
determine if chloride channels are involved in the more-than-additive response previously
reported by Frisbie (Frisbie, R.K. 2006).

The EC50 values of the chloride channel

antagonists were determined from concentration-dependent response curves (Fig. 3)
whereas pyrethroid EC50 values were previously determined (Frisbie, R.K. 2006).
Three criteria were used to determine if the selected chloride channel antagonists
elicited a concentration-dependent response on L-glutamate release.

The data were

initially fit to Equation 2 (Section 2.8) to determine a treatment effect (data generated a
liner regression response that had a slope significantly different zero). If the data met this
criterion, Equation 3 (Section 2.8) was used by fitting the data to the Hill equation to
determine if there was a concentration-dependent response between L-glutamate release
and the dose of the antagonist. Lastly, an F-test was used to determine the best fit of the
data to either Equations 2 or 3.
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Of the five antagonists tested, only NPPB elicited a concentration-dependent
response curve that satisfied all three criteria (F-test, F = 208.2, P < 0.0001, respectively)
(Fig. 3). The concentration-dependent response curve of 9-AC did not reach saturating
conditions at its limit of solubility (~4 mM) (Weinreich, F. 2001), however, the slope was
significantly different from zero as determined by Equation 2 and the data generated a
concentration-dependent response as determined by Equation 3 (Fig. 3). Since GraphPad
Prism (Version 3.02) was able to fit the data to Equation 3 and generate an EC50 value
that was consistent with the literature (Weinreich, F. 2001) despite failure of the F-test
(F-test, F = 1.21, P = 0.5406), 9-AC was used to in the presence of deltamethrin to
determine if a more-than-additive response could be elicited.
ClTx and DNDS also increased L-glutamate release with slopes significantly
different from zero (Equation 2).

GraphPad Prism was able to fit the data to

concentration-dependent response curves and extrapolate an EC50 value for both
antagonists. These values were consistent with those reported by the vendor (Alomone
Labs product information sheet) and in the literature (Dalton, S. 2003), respectively.
Nevertheless, both antagonists were determined to fit the linear regression equation the
best (F-test, F = 0.339 and 4.486, respectively and P = 0.7468 and 0.3167, respectively)
(Fig. 3). The PTX data did not establish a concentration-response relationship that was
significantly different from zero (Equation 2), and hence was not further examined in the
remaining experiments.
Table 6 summarizes the effects of increasing concentrations of chloride channel
antagonists on L-glutamate release. As judged by their estimated EC50s, antagonists
varied by ~ 3 orders of magnitude (7500-fold) from the least potent (9-AC, 2.4 x 10-4 M)
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to the most potent (ClTx, 3.21 x 10-8 M). Data are reported as means ± SE of 3 replicates
from 3 synaptosomal preparations for 9-AC, 7 replicates from 7 synaptosomal
preparations for ClTx, 9 replicates from 6 synaptosomal preparations for DNDS, and 7
replicates from 4 synaptosomal preparations for NPPB.
In terms of maximal response (efficacy), however, NPPB was the most
efficacious at eliciting L-glutamate release from synaptosomes followed by (in order of
decreasing efficacy) ClTx, DNDS, and 9-AC (Table 6). Antagonists varied by 7.7- fold
from the least efficacious (9-AC, 3.64 % ± 4.79) to the most efficacious (NPPB, 28 % ±
1.38).
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Figure 3. Effect of increasing concentrations of chloride channel antagonists on Lglutamate release from K+-depolarized synaptosomes. Anthracene-9-carboxylic acid (9AC), rChlorotoxin (ClTx), 4,4’-dintitrostilbene-2,2’-disulfonic acid (DNDS), 5-nitro-2(3-phenylpropylamino) benzoic acid (NPPB), Picrotoxinin (PTX). KCl (20 mM) was
used to depolarize synaptosomes. Concentration-dependent response curves were fit with
the sigmoidal dose-response (variable slope) function in GraphPad Prism version 3.02.
Data are reported as means ± SE of at least 3 replicates from multiple synaptosome
preparations (n > 3) and presented as percents over solvent controls.
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Table 6. The effects of increasing concentrations of chloride channel antagonists on L-glutamate release from rat brain
synaptosomes.

Hill Slopea
(± SE)

EC50 [M]a
(± 95% CI)

Maximum Responsea
(% Over Control)
(± SE)

R2b

9-AC

0.58 (±1.09)

2.4 x 10-4
( 1.6 x 10-37 to 3.6 x 10+29 )

3.64 (± 4.79)

0.98

ClTx

0.76 (±0.88)

3.2 x 10-8
( 5.1 x 10-11 to 2.0 x 10-5 )

4.07 (± 1.15)

0.96

DNDS

1.60 (±0.81)

8.7 x 10-7
( 1.1 x 10-9 to 7.0 x 10-6 )

3.66 (± 0.15)

0.99

NPPB

0.65 (± 0.07)

2.3 x 10-4
(1.2 x 10-4 to 4.4 x 10-4)

28.0 (± 1.38)

0.99

Antagonists
c
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a

Estimates were derived from the Hill equation using GraphPad Prism (version 3.02).
Correlation Coefficient.
c
Saturation was not achieved at highest concentration examined.
b

3.2 Effect of Pyrethroids in Equipotent Binary Mixtures with Chloride Channel
Antagonists on L-glutamate Release from Synaptosomes

Chloride channel antagonists (9-AC, ClTx, DNDS, and NPPB) at their respective
EC50 values were incubated with cypermethrin (type II, CS-syndrome), deltamethrin
(type II, CS-syndrome), fenpropathrin (type II, T-syndrome), and tefluthrin (type I, Tsyndrome) at their respective EC50 values to determine if chloride channels play a role in
the more-than-additive effect previously seen with the four binary mixtures of
pyrethroids reported by Frisbie (Frisbie, R.K. 2006).
9-AC (1 x 10-4 M) in the presence of deltamethrin (2 x 10-12 M) had no effect on
L-glutamate release (Fig. 4).

Compared to the theoretical mixture response (assay

response value of synaptosomes in the presence of 9-AC alone at its EC50 added to the
assay response value of deltamethrin alone at its EC50), 9-AC in the presence of
deltamethrin increased L-glutamate release 1.6-fold, however, this increase was not
statistically significant and therefore was not considered to contribute to the more-thanadditive response (unpaired t-test, P = 0.9562) (Fig. 4 and Table 7). Because none of the
treatments were significantly different from each other (One-way ANOVA, Tukey’s
multiple comparison post-test, GraphPad Prism, Version 3.02) and since 9-AC did not
elicit a more-than-additive response on L-glutamate release in the presence of
deltamethrin, the remaining pyrethroids were not similarly tested.
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Figure 4. Percent additivity of an equipotent binary mixture of 9-AC and deltamethrin
(both at their respective EC50s), on L-glutamate release from rat brain synaptosomes.
Data are reported as means ± SE of 7 replicates from multiple synaptosome preparations
(n = 3) and are presented as percents over the solvent control. An asterisk (*) indicates
that concentration used in the assay was obtained from literature. Values in parentheses
indicate a negative response on L-glutamate release.
Abbreviations: Delta = deltamethrin
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ClTx (1 x 10-7 M) in the presence of deltamethrin (2 x 10-12 M) significantly
increased L-glutamate release 26-fold compared to synaptosomes treated with ClTx alone
(unpaired t-test, P = 0.004).

This release was increased 1.5-fold compared to

synaptosomes treated with deltamethrin alone, but this increase was not significant
(unpaired t-test, P = 0.2727) (Fig. 5). The actual response value of ClTx in binary
mixture with deltamethrin increased L-glutamate release 1.5-fold compared to the
theoretical mixture response, but the increase was not significant (unpaired t-test, P =
0.4124).

Using the percent additivity equation (Equation 4), the actual response

increased 48% over the theoretical. This increase, nevertheless, was not statistically
significant indicating that a more-than-additive response was not generated (unpaired ttest, P = 0.412) (Fig. 5 and Table 7). Using the one-way ANOVA and Tukey’s multiple
comparison post-test, it was determined that none of the treatments were actually
significantly different from each other, with the exception of ClTx plus deltamethrin
compared to ClTx alone (GraphPad Prism, Version 3.02). Since ClTx did not elicit a
more-than-additive response on L-glutamate release when in the presence of
deltamethrin, the remaining pyrethroids were not similarly tested.
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Figure 5. Percent additivity of an equipotent binary mixture of ClTx and deltamethrin,
(both at their respective EC50s), on L-glutamate release from rat brain synaptosomes.
Data are reported as means ± SE of 9 replicates from multiple synaptosome preparations
(n = 7) and are presented as percents over the solvent control. A closed circle (●)
indicates that respective treatment is significantly greater than NT + ClTx treatment
(unpaired t-test, p < 0.05, GraphPad Prism version 3.02).
Abbreviations: Delta = deltamethrin
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DNDS (2 x 10-6 M) in the presence of deltamethrin (2 x 10-12 M) increased Lglutamate release ~ 5-fold compared to synaptosomes treated with DNDS alone and 1.4fold compared to synaptosomes treated with deltamethrin alone (Fig. 6). None of the
increases were, however, significant (unpaired t-test, P = 0.2627 and 0.5111,
respectively). The actual response value of DNDS in binary mixture with deltamethrin
increased release 1.1-fold compared to the theoretical mixture response, however, this
increase was not statistically significant. Thus a more-than-additive response was not
generated (unpaired t-test, P = 0.9281) (Fig. 6 and Table 7). Furthermore, none of the
treatments were significantly different from each other (One-way ANOVA, Tukey’s
multiple comparison post-test, GraphPad Prism, Version 3.02).
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Figure 6. Percent additivity of an equipotent binary mixture of DNDS and deltamethrin
(both at their respective EC50s), on L-glutamate release from rat brain synaptosomes.
Data are reported as means ± SE of 4 replicates from multiple synaptosome preparations
(n = 4) and are presented as percents over the solvent control. An asterisk (*) indicates
that concentration used in the assay was obtained from literature.
Abbreviations: Delta = deltamethrin
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NPPB (7 x 10-5 M) in the presence of deltamethrin (2 x 10-12 M) (reported as
means ± SE of 18 replicates from 7 synaptosomal preparations) significantly increased Lglutamate release 3.4-fold compared to synaptosomes treated with NPPB alone (unpaired
t-test, P < 0.0001) and 3.5-fold compared to synaptosomes treated with deltamethrin
alone (unpaired t-test, P < 0.0001) (Fig. 7A). The actual response value of NPPB in
binary mixture with deltamethrin significantly increased L-glutamate release 1.7-fold
compared to the theoretical mixture response (unpaired t-test, P = 0245). Using the
percent additivity equation (Equation 4), the actual response increased 73% over the
theoretical and was determined to have elicited a more-than-additive response on Lglutamate release (Fig 7A and Table 7).

In addition, only the actual treatment of

deltamethrin plus NPPB was determined to be significantly different from all other
treatments (One-way ANOVA, Tukey’s multiple comparison post-test, GraphPad Prism,
Version 3.02).
To assess if this more-than-additive response was only generated by the NPPB
plus deltamethrin mixture, NPPB was likewise examined in binary combinations with a
slightly less potent type II pyrethroid that modifies VGSCs, VGCCS, and VGClCs,
cypermethrin (Fig. 7B); a pyrethroid that is type II, but exhibits the T-syndrome and
modifies VGSCs and VGClCs, fenpropathrin (Fig. 7C); and a type I pyrethroid that
modifies VGSCs only, tefluthrin (Fig. 7D). Cypermethrin and NPPB (2 x 10-10 and 7 x
10-5 M, respectively) in binary mixture (reported as means ± SE of 4 replicates from 4
synaptosomal preparations) significantly increased L-glutamate release ~ 35-fold
compared to synaptosomes treated with NPPB alone (unpaired t-test, P = 0.0056) and
significantly increased L-glutamate release 4.5-fold compared to synaptosomes treated
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Figure 7. Percent additivity of an equipotent binary mixture of NPPB and deltamethrin
(A), cypermethrin (B), fenpropathrin (C), and tefluthrin (D), (both at their respective
EC50s) on L-glutamate release from rat brain synaptosomes. Data are reported as means
± SE of at least 3 replicates from multiple synaptosome preparations (n >3) and are
presented as percent over the solvent control. A closed circle (●) indicates that respective
treatment is significantly greater than NT + NPPB treatment (unpaired t-test, p < 0.05,
GraphPad Prism version 3.02). An open triangle (∆) indicates that respective treatment is
significantly greater than pyrethroid treatment alone (unpaired t-test, p < 0.05, GraphPad
Prism version 3.02). A closed square (■) indicates that respective treatment is
significantly greater than theoretical mixture (unpaired t-test, p < 0.05, GraphPad Prism
version 3.02).
Abbreviations: Delta = deltamethrin, Cyper = cypermethrin, Fenpro = fenpropathrin, and
Tef = tefluthrin.
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with cypermethrin alone (unpaired t-test, P = 0.0166) (Fig. 7B). The actual response
value of NPPB in binary mixture with cypermethrin significantly increased 4-fold
compared to the theoretical mixture response (unpaired t-test, P = 0.0308). Using the
percent additivity equation (Equation 4), the actual response significantly increased Lglutamate release 298% over the theoretical mixture (Fig. 7B). In addition, only the
actual treatment of cypermethrin plus NPPB was determined to be significantly different
from all other treatments (One-way ANOVA, Tukey’s multiple comparison post-test,
GraphPad Prism, Version 3.02).
NPPB in the presence of fenpropathrin (7 x 10-5 and 2 x 10-9 M, respectively)
(reported as means ± SE of 11 replicates from 6 synaptosomal preparations) significantly
increased L-glutamate release 4-fold compared to synaptosomes treated with NPPB alone
(unpaired t-test, P = 0.0005) and significantly increased L-glutamate release 4.4-fold
compared to synaptosomes treated with fenpropathrin alone (unpaired t-test, P < 0.0001)
(Fig. 7C). The actual response value of NPPB in binary mixture with fenpropathrin
significantly increased 2-fold compared to the theoretical mixture response (unpaired ttest, P = 0.0121). Using the percent additivity equation (Equation 4), the actual response
increased significantly 112% over the theoretical mixture (Fig. 7C). In addition, only the
actual treatment of fenpropathrin plus NPPB was determined to be significantly different
from all other treatments (One-way ANOVA, Tukey’s multiple comparison post-test,
GraphPad Prism, Version 3.02).
NPPB in the presence of tefluthrin (7 x 10-5 and 2 x 10-8 M, respectively)
(reported as means ± SE of 7 replicates from 4 synaptosomal preparations) significantly
increased L-glutamate release 4.4-fold compared to synaptosomes treated with NPPB
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alone (unpaired t-test, P = 0.0038) and significantly increased L-glutamate release 10fold compared to synaptosomes treated with tefluthrin alone (unpaired t-test, P = 0.0004)
(Fig. 7D).

The actual response value of NPPB in binary mixture with tefluthrin

significantly increased 3-fold compared to the theoretical mixture response (unpaired ttest, P = 0.0162). Using the percent additivity equation (Equation 4), the actual response
increased significantly 208% over the theoretical mixture (Fig. 7D). In addition, only the
actual treatment of tefluthrin plus NPPB was determined to be significantly different
from all other treatments (One-way ANOVA, Tukey’s multiple comparison post-test,
GraphPad Prism, Version 3.02).
Since tefluthrin modifies only VGSCs, the addition of a chloride channel
antagonist such as NPPB should mimic the response seen with fenpropathrin, which
modifies both VGSCs and VGClCs. When the assay response of fenpropathrin alone
(2.15 % ± 0.57) was compared to the assay response of tefluthrin in an equipotent binary
mixture with NPPB (7.03 % ± 1.07), it was found that the L-glutamate release increased
by 3.3-fold and was statistically significant (unpaired t-test, P = 0.0004). When the assay
response of tefluthrin in an equipotent binary mixture with NPPB was compared to the
assay response of deltamethrin alone (2.41 % ± 0.64), L-glutamate release increased 2.9fold and was statistically significant (unpaired t-test, P = 0.003). Likewise, when
tefluthrin in the presence of NPPB was compared to cypermethrin alone (2.0 % ± 1.24),
L-glutamate release significantly increased 3.5-fold (unpaired t-test, P = 0.0261).
Table 7 summarizes the effect of chloride channel antagonists at their estimated
EC50s on L-glutamate release in the presence of deltamethrin at its EC50 (2 x 10-12 M) on
rat brain synaptosomes.
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Table 7: Effect of chloride channel antagonists at their EC50s on L-glutamate release from rat brain synaptosomes in
the presence of deltamethrin at its EC50 (2 x 10-12 M).

EC50

Theoretical Responsea Actual Responseb
(± SE)
(± SE)

Significantly
Different
(p < 0.5)

%
Additivityc

Antagonist
64
a

9-AC

0.1 mM

0.48% (± 4.60)

0.77 % (± 2.39)

No

-

ClTx

0.1 µM

2.80 % (± 1.07)

4.08 % (± 1.10)

No

48 %

DNDS

2 µM

4.37% (± 3.98)

4.77% (± 1.61)

No

-

NPPB

70 µM

4.85% (± 1.17)

8.37% (± 0.71)

Yes

73 %

Theoretical response determined by the sum of the individual L-glutamate release response values in the presence of each
pyrethroid alone at its EC50.
b
Actual response is the lowest concentration of pyrethroids in binary mixture observed that exhibited a more-than-additive
response on L-glutamate release in the presence of NPPB (70 µM).
c
Percent (%) additivity values for pyrethroid binary mixtures were calculated using Equation 4 (Section 2.8).

3.3 Discussion

Concentration-response curves were generated for four of the five chloride
channel antagonists, 9-AC, ClTx, DNDS, and NPPB, all of which increased L-glutamate
release from rat brain synaptosomes. The estimated EC50 values for 9-AC, ClTx, DNDS,
and NPPB (2.39 x 10-4 M, 3.21 x 10-8 M, 1.65 x 10-6 M, and 2.30 x 10-4, respectively)
from our concentration response curves were consistent with previously established
potency values in similar neuronal preparations (Weinreich, F. 2001; Clark, S. 1998;
Dalton, S. 2003; Okada, Y. 2000).
PTX failed to elicit a treatment response on L-glutamate release that was
significantly different from a slope of zero. Historically, the modulation of GABAAClCs
by the inhibitory neurotransmitter, GABA, has been well established as occurring on
postsynaptic targets (Jang, I.S. 2006). Recent evidence, however, suggests that these
receptors are found also on presynaptic membranes (Zhang, S.J. 1993; Vautrin, J. 1994;
Jang, I.S. 2006). Because of this, it is not clear why PTX was incapable of eliciting a
concentration-dependent response on L-glutamate release from rat brain synaptosomes.
Although the level of expression of these receptors is not known in our preparation, it is
possible that the neurotransmitter release assay is too insensitive to detect the amount of
L-glutamate release due to inhibition of GABAAClCs. In addition, Vautrin et al. describe
mechanisms by which synaptic transmission is mediated and seems likely that rat brain
synaptosomes modulate transmission via presynaptic auto-transmission or “cis-mission”
(Vautrin, J. 1994). If this were true, then it would be expected that both excitatory and
inhibitory neurotransmitters would feedback on their respective receptors on the
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presynaptic nerve terminal and an inability of one receptor to mediate synaptic
transmission this way is expected to be the same for other receptors.
Using the established potency values for 9-AC, ClTx, DNDS, and NPPB,
equipotent binary mixtures of the chloride channel antagonists and pyrethroids could be
examined for a potential contribution of chloride channels to the more-than-additive
response on L-glutamate release.
Deltamethrin was chosen as the initial pyrethroid to test because it has been
established previously as the most potent pyrethroid on L-glutamate release from rat
brain synaptosomes (Frisbie, R.K. 2006). Since the neurotoxic action of deltamethrin
includes the modification of neuronal VGClC in addition to VGSC and VGCC (Chinn,
K. 1986; Symington, S.B. 2005; Forshaw, P.J. 1990), it was hypothesized that blocking
chloride channels with selective antagonists in the presence of deltamethrin should
increase L-glutamate release and contribute to the more-than-additive response.
Collectively, our findings indicated that only NPPB was capable of significantly
increasing L-glutamate release 73% when in equipotent binary mixtures with
deltamethrin and reproduce the more-than-additive response previously seen with certain
binary mixtures of pyrethroids (Frisbie, R.K. 2006). Although the equipotent binary
mixture of ClTx and deltamethrin was not significantly different from the theoretical
response, the percent additivity of this equipotent binary mixture was calculated (48%)
for comparative purposes since ClTx was previously established as the most potent of all
the tested antagonists. Additionally, the treatments were determined to be significantly
different from each other using the one-way ANOVA and Tukey’s multiple comparison
post-test. 9-AC and DNDS did not significantly increase L-glutamate release in the
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presence of deltamethrin and treatments were not determined to be significantly from
each other. Hence, these compounds were not investigated further.
The effect of NPPB on L-glutamate release was investigated with three additional
pyrethroids. Cypermethrin, like deltamethrin, has been shown to modify the gating
kinetics of VGSCs, VGCCs, and VGClCs. Fenpropathrin modifies VGSCs and VGClCs,
while tefluthrin modifies only VGSCs (Soderlund, D.M. 2002; Frisbie, R.K. 2006; Burr,
S.A. 2004).

In all three respective equipotent binary mixtures with cypermethrin,

fenpropathrin, and tefluthrin, NPPB significantly increased L-glutamate release by 298,
112, and 208 %, respectively, when compared to the theoretical assay response and all
treatments were significantly different from each other, as determined by the one-way
ANOVA.
A more-than-additive response of L-glutamate release from rat brain
synaptosomes occurred in the presence of binary mixtures of pyrethroids where at least
one of the two pyrethroids increased neurotransmitter release and the other pyrethroid
had an action on VGClCs (Frisbie, R.K. 2006). This phenomenon is likewise seen only
in the combined presence of a pyrethroid that increases L-glutamate release and a
chloride channel antagonist which blocks VGClCs in presynaptic nerve terminals, such as
ClTx and NPPB, indicating that blockage of VGClCs may be necessary for the
generation of the more-than-additive response.
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CHAPTER 4

EFFECTS OF CHLORIDE CHANNEL ANTAGONIST ON
NEUROTRANSMITTER RELEASE FROM SYNAPTOSOMES IN THE
COMBINED PRESENCE OF EQUIPOTENT PYRETHROID BINARY
MIXTURES

4.1 Effect of NPPB on Pyrethroid Binary Mixtures that Produced a More-ThanAdditive Response on L-Glutamate Release

The potency (EC50) value for NPPB on L-glutamate release was determined from
concentration-dependent response data as 70 µM (Section 3.1) and used in the presence
of two equipotent binary mixtures of pyrethroids (deltamethrin plus cypermethrin and
deltamethrin plus fenpropathrin) that produced more-than-additive responses (Frisbie,
R.K. 2006).
Figure 8A depicts the effects of deltamethrin and cypermethrin, individually and
in binary mixture, on endogenous L-glutamate release (Frisbie, R.K. 2006).
Synaptosomes were treated with either the EC50 of deltamethrin alone (2 x 10-12 M, final
concentration), cypermethrin alone (2 x 10-10 M, final concentration) or with binary
mixtures of deltamethrin and cypermethrin. Binary mixtures ranged from a 1:1 to 1:100
ratio of 2 x 10-12 M deltamethrin with increasing concentrations of cypermethrin (2 x 1012

M to 2 x 10-10 M) (final total pyrethroid concentrations were 4 x 10-12 M to 2.02 x 10-10

M). A combined theoretical mixture response of deltamethrin and cypermethrin (4 x 10-
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12

M, final concentration) was generated by the addition of the assay response values for

the two pyrethroids determined individually at their respective EC50 values.
Figure 8B depicts the effects of deltamethrin and cypermethrin individually and in
binary mixture with 70 µM NPPB on endogenous L-glutamate release. Treatments were
conducted as described above, but in the presence of 70 µM NPPB. All binary mixtures
tested (1:1, 1:10, 1: 100), significantly increased (7.4-, 8.6-, 6.7-fold respectively) Lglutamate release compared to the deltamethrin treatment alone (0.78% ± 0.69) (unpaired
t-test, P = 0.0036, 0.0062, and 0.0091, respectively).
When compared to the theoretical mixture, the deltamethrin plus cypermethrin
actual mixtures (1:1, 1:10, 1:100) in the presence of NPPB increased L-glutamate
release 2.7-, 3.1-, and 2.4-fold, respectively. However, only the 1:1 and 1:10 mixtures
resulted in statistically greater release (unpaired t-test, P = 0.0293, 0.0300, and 0.0659,
respectively). Using the % additivity criteria (Equation 4), the 1:1 ratio of deltamethrin
plus cypermethrin with NPPB at the 1:1 ratio ( 5.80 % ± 1.02) elicited a more-thanadditive response that was 166 % more than the theoretical response (2.18 % ± 0.91)
(Fig. 8B) . Thus, the more-than-additive response previously reported in the absence of
NPPB (1:100) (Fig. 8A) (Frisbie, R.K. 2006) was shifted to a lower concentration of
cypermethrin by one order of magnitude (1:10) (Fig. 8B)
Figure 9A depicts the effects of deltamethrin plus fenpropathrin, individually and
in binary mixture, on endogenous L-glutamate release (Frisbie, R.K. 2006).
Synaptosomes were treated with either the EC50 of deltamethrin alone (2 x 10-12 M, final
concentration), fenpropathrin alone (2 x 10-8 M, final concentration) or with
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Figure 8: Determination of additivity between deltamethrin and cypermethrin in the
absence (A) (reproduced from Richard K. Frisbie M.S. thesis, University of
Massachusetts, Amherst, © 2006) and presence (B) of NPPB (70 µM), on L-glutamate
release from rat brain synaptosomes. Values reported are means ± SE of 10 replicates
from multiple synaptosomal preparations (n = 5). KCl (20 mM) was used to depolarize
synaptosomes. Synaptosomes were treated with either the EC50 of deltamethrin alone
([final assay] 2 x 10-12 M), the EC50 of cypermethrin alone ([final assay] 2 x 10-10 M) or a
binary mixture in the presence of NPPB (70 µM). An asterisk (*) indicates the
theoretical mixture response determined as the sum of the individual assay response
values for deltamethrin and cypermethrin at their respective EC50 values. A closed circle
(●) indicates the actual mixture response values for L-glutamate release in the presence
of NPPB (70 µM) and binary mixtures composed of deltamethrin ([final assay] 2 x 10-12
M) and increasing concentrations of cypermethrin ([final assay] 2 x 10-12 to 2 x 10-10 M),
([final total pyrethroid assay] 4 x 10-12 to 2.02 x 10-10 M). An open triangle (∆) indicates
that the actual mixture is significantly greater than the deltamethrin treatment alone
(unpaired t-test, P < 0.05). A closed square (■) indicates that actual mixture is
significantly greater than the theoretical response (unpaired t-test, P < 0.05).
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binary mixtures of deltamethrin and fenpropathrin in the presence of 70 µM NPPB.
Binary mixtures ranged from a 1:1 to 1:10,000 ratio of deltamethrin to increasing
concentrations of fenpropathrin (final total pyrethroid concentrations were 4 x 10-12 M to
2.0002 x 10-8 M).

A combined theoretical mixture response of deltamethrin and

fenpropathrin (4 x 10-12 M, final concentration) was generated as before.
Figure 9B depicts the effects of deltamethrin and fenpropathrin individually and
in binary mixture with 70 µM NPPB on endogenous L-glutamate release. Treatments
were conducted as described above, but in the presence of 70 µM NPPB. At all binary
mixtures (1:1 to 1:10,000) tested, deltamethrin in the presence of increasing
concentrations of fenpropathrin and 70 µM NPPB, significantly increased L-glutamate
release (22-, 21-, 23-, 27-, and 26-fold, respectively) when compared to deltamethrin
treatment alone (unpaired t-test, P = 0.0007, 0.001, 0.0014, 0.0008, and 0.0003,
respectively).
Additionally, all binary mixtures (1:1 to 1:10,000) in the presence of NPPB
significantly increased L-glutamate release (6.2-, 5.9-, 6.4-, 7.7-, 7.2-fold, respectively)
when compared to the theoretical mixture (2.0002 x 10-8 M), (unpaired t-test, P = 0.0021,
0.0033, 0.0037, 0.0019, and 0.0008, respectively).

Using the % additivity criteria

(Equation 4), the 1:1 ratio of deltamethrin plus fenpropathrin with NPPB elicited a morethan-additive response that was 524 % more than the theoretical response (1.49 % ±
0.82).
Thus, the more-than-additive response previously reported in the absence of
NPPB (1:1,000) (Fig. 9A) (Frisbie, R.K. 2006) was shifted to a lower concentration of
fenpropathrin by three orders of magnitude (1:1) (Fig. 9B).
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Figure 9: Determination of additivity between deltamethrin and fenpropathrin in the
absence (A) (reproduced from Richard K. Frisbie M.S. thesis, University of
Massachusetts, Amherst, © 2006) and presence (B) of NPPB (70 µM), on L-glutamate
release from rat brain synaptosomes. Values reported are means ± SE of 5 replicates
from multiple synaptosomal preparations (n = 3). KCl (20 mM) was used to depolarize
synaptosomes. Synaptosomes were treated with either the EC50 of deltamethrin alone
([final assay] 2 x 10-12 M), the EC50 of fenpropathrin alone ([final assay] 2 x 10-8 M) or a
binary mixture in the presence of NPPB (70 µM). An asterisk (*) indicates the
theoretical mixture response determined as the sum of the individual assay response
values for deltamethrin and fenpropathrin at their respective EC50 values. A closed circle
(●) indicates the actual mixture response values for L-glutamate release in the presence
of NPPB (70 µM) and binary mixtures composed of deltamethrin ([final assay] 2 x 10-12
M) and increasing concentrations of fenpropathrin ([final assay] 2 x 10-12 to 2 x 10-8 M),
([final total pyrethroid assay] 4 x 10-12 to 2.0002 x 10-8 M). An open triangle (∆)
indicates that the actual mixture is significantly greater than the deltamethrin treatment
alone (unpaired t-test, P < 0.05). A closed square (■) indicates that the actual mixture is
significantly greater than the theoretical response (unpaired t-test, P < 0.05).
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4.2 Effect of NPPB in the Presence of a Pyrethroid Binary Mixture that Produced
an Additive Response on L-Glutamate Release

To further validate a role of chloride channels in producing the more-thanadditive response seen with certain binary mixtures of pyrethroids, the chloride channel
antagonist, NPPB, was used in the presence of a binary mixture of pyrethroids that
elicited an additive response on L-glutamate release. The potency (EC50) value for the
chloride channel antagonist, NPPB, was determined from a concentration-response curve
(Section 3.1) and used in the presence of an additive binary mixture, deltamethrin plus
tefluthrin (Frisbie, R.K. 2006).
Figure 10A depicts the effects of deltamethrin and tefluthrin in binary mixture on
endogenous L-glutamate release.

Synaptosomes were treated with either the EC50 of

deltamethrin alone (2 x 10-12 M, final concentration), the EC50 of tefluthrin alone (2 x 10-9
M, final concentration) or with binary mixtures of deltamethrin plus tefluthrin with 70
µM NPPB.

Binary mixtures ranged from a 1:1 to 1:1,000 ratio of 2 x 10-12 M

deltamethrin with increasing concentrations of tefluthrin (2x10-12 to 2x10-9 M final
concentration) (final total pyrethroid concentrations were 4 x 10-12 M to 2.002 x 10-9 M).
A combined theoretical mixture response of deltamethrin and tefluthrin (4 x 10-12 M, final
concentration) was generated as before.
Figure 10B depicts the effects of deltamethrin and tefluthrin individually, and in
binary mixture with 70 µM NPPB on endogenous L-glutamate release. Treatments were
conducted as above, but in the presence of 70 µM NPPB. All binary mixtures (1:1 to
1:1,000) in the presence of NPPB significantly increased (17-, 23-, 19-, and 18-fold,
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respectively) L-glutamate release when compared to the deltamethrin treatment alone
(unpaired t-test, P = 0.0133, 0.0012, 0.0023, 0.0008, and 0.0022, respectively). When
compared to the theoretical treatment, deltamethrin and tefluthrin in the presence of
NPPB increased L-glutamate release (3.1-, 4.2-, 3.4-, and 3.3-fold, respectively), but only
the mixtures from 1:10 to 1:1000 were significantly different from the theoretical
response (unpaired t-test, P = 0.0075, 0.0188, and 0.0207, respectively). Using the %
additivity criteria (Equation 4), deltamethrin and tefluthrin in the presence of NPPB at the
1:10 ratio (7 % ± 1.12) elicited a more-than-additive response that was 324 % more than
1:1,000 theoretical mixture (1.65 % ± 0.76).
Overall, these findings suggest that NPPB is capable of synergizing the effect of
deltamethrin on L-glutamate release from rat brain synaptosomes. Previous studies have
shown that deltamethrin and tefluthrin, when in binary combination, elicit only an
additive response on L-glutamate release (Frisbie, R.K. 2006). However, the effect of
these compounds when in binary mixtures, on L-glutamate release, can be enhanced by
antagonizing the chloride channel.
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Figure 10: Determination of additivity between deltamethrin and fenpropathrin in the
absence (A) (reproduced from Richard K. Frisbie M.S. thesis, University of
Massachusetts, Amherst, © 2006) and presence (B) of NPPB (70 µM), on L-glutamate
release from rat brain synaptosomes. Values reported are means ± SE of 5 replicates
from multiple synaptosomal preparations (n = 3). KCl (20 mM) was used to depolarize
synaptosomes. Synaptosomes were treated with either the EC50 of deltamethrin alone
([final assay] 2 x 10-12 M), the EC50 of fenpropathrin alone ([final assay] 2 x 10-8 M) or a
binary mixture in the presence of NPPB (70 µM). An asterisk (*) indicates the
theoretical mixture response determined as the sum of the individual assay response
values for deltamethrin and fenpropathrin at their respective EC50 values. A closed circle
(●) indicates the actual mixture response values for L-glutamate release in the presence
of NPPB (70 µM) and binary mixtures composed of deltamethrin ([final assay] 2 x 10-12
M) and increasing concentrations of fenpropathrin ([final assay] 2 x 10-12 to 2 x 10-8 M),
([final total pyrethroid assay] 4 x 10-12 to 2.0002 x 10-8 M). An open triangle (∆)
indicates that the actual mixture is significantly greater than the deltamethrin treatment
alone (unpaired t-test, P < 0.05). A closed square (■) indicates that the actual mixture is
significantly greater than the theoretical response (unpaired t-test, P < 0.05).
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L-Glutamate Released
(% of Total L-Glutamate)

A

20.0

1R-Deltamethrin
Tefluthrin
Theoretical Mixture; 1:1,000*
Actual Mixture; 1:1
Actual Mixture; 1:10
 where 1 = EC 50 deltamethrin
Actual Mixture; 1:100
Actual Mixture; 1:1,000

17.5
15.0
12.5
10.0
7.5
5.0
2.5
0.0
20.0

1R-Deltamethrin
Tefluthrin
Theoretical Mixture; 1:1,000*
Actual Mixture; 1:1
Actual Mixture; 1:10
 where 1 = EC 50 deltamethrin
Actual Mixture; 1:100
Actual Mixture; 1:1,000

17.5
15.0
12.5
10.0
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4.3 Discussion

In order to establish a role of chloride channel blockage in producing the morethan-additive response on L-glutamate release, NPPB, the most efficacious of the
chloride channel antagonists identified in our study, was used in the presence of two
more-than-additive pyrethroid binary mixtures and one additive pyrethroid binary
mixture previously established by Frisbie.(Frisbie, R.K. 2006).
Since chloride channels generally function to rectify membrane potential (Hille,
B. 2001), it was expected that blocking such channels in isolated presynaptic nerve
terminals (synaptosomes) would increase membrane depolarization and cause an increase
in L-glutamate alone.
In the presence of the binary mixtures that elicit a more-than-additive response
(deltamethrin plus cypermethrin and deltamethrin plus fenpropathrin), it was expected
that NPPB would shift the more-than-additive response to a lower combined
concentration of the two pyrethroids in binary mixtures and that the more-than-additive
response would increase in a concentration-dependent manner as seen by Frisbie.
(Frisbie, R.K. 2006). In the presence of an additive binary mixture (deltamethrin plus
tefluthrin), it was expected that a more-than-additive response on L-glutamate release
would be generated, but that a concentration-dependent response would not be elicited.
Our findings indicate that chloride channels do play a role in eliciting a morethan-additive response.
Table 8 summarizes the relationship of binary mixtures of pyrethroids in the
presence of 70 µM NPPB on endogenous L-glutamate release from rat brain
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synaptosomes.

Deltamethrin in equipotent binary mixtures with cypermethrin,

fenpropathrin, and tefluthrin, increased L-glutamate release (166, 524, and 324 %
respectively) compared to the theoretical response.

These responses were all

significantly different from the theoretical response, indicating a more-than-additive
response has occurred as judged by the % additivity criteria (Equation 4).
Table 9 summarizes the results of adding NPPB to binary mixtures of pyrethroids
that elicited either more-than-additive or additive responses and compared these effects to
those elicited by binary mixtures without NPPB. Deltamethrin plus cypermethrin in the
absence of NPPB first elicited a more-than-additive response at the 1:100 mixture. With
NPPB, this response was first detected with the 1:1 mixture. Thus, the more-thanadditive response was elicited at a 100-fold lower cypermethrin concentration and the
amount of L-glutamate release was enhanced 2.4-fold compared to synaptosomes treated
at the 1:100 mixture without NPPB.
Deltamethrin plus fenpropathrin in the absence of NPPB first elicited a morethan-additive response at the 1: 1,000 mixture. With NPPB, this response was first
detected with the 1:1 mixture. Thus, the more-than-additive response was elicited at a
1000-fold lower fenpropathrin concentration and the amount of L-glutamate release was
enhanced 6.6-fold compared to synaptosomes treated at the 1:1,000 mixture without
NPPB.
Deltamethrin plus tefluthrin in the absence of NPPB did not elicit a more-thanadditive response. With NPPB, a more-than-additive response was first detected with the
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Table 8: Relationship of binary mixtures of pyrethroids in the presence of NPPB (70 µM) on endogenous L-glutamate release from
rat brain synaptosomes.
L-glutamate Released (% of Total L-glutamate)
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a

Pyrethroid Binary Mixture

Ratioa

Theoretical Mixture Responseb
(± SE)

Actual Mixture Responsec
(± SE)

% Additivityd

Deltamethrin + Cypermethrin

1:1

2.18 (± 0.91)

5.8 (± 1.02)*

166 %

Deltamethrin + Fenpropathrin

1:1

1.49 (± 0.82)

9.30 (± 1.55)*

524 %

Deltamethrin + Tefluthrin

1:10

1.65 % (± 0.76)

7.0 % (± 1.12)*

324 %

Observed potency ratio of pyrethroids in binary mixture that exhibited the more-than-additive response in the presence of NPPB
(70 µM) where 1 equals the EC50 of deltamethrin (2 x 10-12 M).
b
Theoretical response determined by the sum of the individual L-glutamate release response values in the presence of each
pyrethroid alone at its EC50.
c
Actual response is the lowest concentration of pyrethroids in binary mixture observed that exhibited a more-than-additive response
on L-glutamate release in the presence of NPPB (70 µM).
d
Percent (%) additivity values for pyrethroid binary mixtures were calculated using Equation 4 (Section 2.8).
* An asterisk indicates that the actual mixture response is statistically different from the theoretical mixture response, unpaired t-test,
P < 0.05 (GraphPad Prism).

Table 9: Comparison of binary mixtures in the absence and presence of NPPB.
Assay Response a,b
- NPPB (70 µM)
(± SE)

Assay Response a
+ NPPB (70 µM)
(± SE)

Fold-increase

1:1

2.4 ( ± 0.17)

5.8 ( ± 1.02) *

2.4

1:10

2.5 ( ± 0.22)

6.7 ( ± 1.45)

2.7

1:100

4.4 ( ± 0.26)*

5.22 ( ± 1.10)

1.2

1:1

1.4 ( ± 0.31)

9.3 ( ± 1.55)*

6.6

1:10

2.3 ( ± 0.34)

8.8 ( ± 1.57)

3.8

1:100

2.4 ( ± 0.34)

9.5 ( ± 1.81)

4.0

1:1,000

4.0 ( ± 0.31)*

11.5 ( ± 2.04)

2.9

1:10,000

7.6 ( ± 0.46)

10.8 ( ± 1.58)

1.4

1:1

1.3 ( ± 0.52)

5.1 ( ± 1.35)

3.8

1:10

2.2 ( ± 0.54)

7.0 ( ± 1.12)*

3.2

1:100

2.53 ( ± 0.37)

5.7 ( ± 1.00)

2.2

1:1,000

3.0 ( ± 0.50)

5.4 ( ± 0.95)

1.8

Equipotent Binary Mixture
Deltamethrin + Cypermethrin

Deltamethrin + Fenpropathrin
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Deltamethrin + Tefluthrin

a

Assay response is the amount of L-glutamate released in the presence of a binary mixture of pyrethroids with or without NPPB.
Values obtained from work done by Frisbie (Frisbie, R.K. 2006).
* An asterisk indicates the lowest concentration at which a more-than-additive response L-glutamate release was observed.

b

1:10 mixture. The amount of L-glutamate release was enhanced 3.2-fold compared to
synaptosomes treated at the 1:10 mixture without NPPB.
Overall, the more-than-additive binary mixtures (deltamethrin plus cypermethrin
and deltamethrin plus fenpropathrin) in the presence of NPPB shifted this response to
lower binary mixture concentrations and the additive binary mixture (deltamethrin plus
tefluthrin) in the presence of NPPB elicited a more-than-additive response as expected.
None of the pyrethroid binary mixtures in the presence of NPPB, however, elicited Lglutamate release in a concentration-dependent manner.

It is possible that the

concentration of NPPB used saturated certain chloride channels that are target sites for
selected pyrethroids and hence a concentration effect on L-glutamate release could not be
distinguished using the different ratios of pyrethroids in binary mixtures.

Lower

concentrations of NPPB should be tested to clarify this effect. In addition, since the
additive binary mixture, deltamethrin plus tefluthrin with NPPB elicited a more-thanadditive response on L-glutamate release, it is not clear whether this response is due to
the action of NPPB at the chloride channels alone or if this inhibitor enhances the action
of tefluthrin at VGSCs. Therefore, the VGSC inhibitor, tetrodotoxin (TTX), could be
used in the presence of this pyrethroid binary mixture with NPPB to determine if the
more-than-additive response is abolished. If this response is abolished, it suggests that
modifying chloride channels ultimately modulates sodium conductance via VGSCs and
this action is important also for pyrethroids that affect only VGSCs.
Similar to NPPB, ClTx in the presence of select binary mixtures can also enhance
L-glutamate and shift the more-than-additive response to lower concentrations (Frisbie,
R.K. 2006). Deltamethrin plus fenpropathrin in the absence of ClTx first elicited the
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more-than-additive response at the 1:1,000 mixture. With ClTx, this response was first
detected with the 1:10 mixture (2.65 ± 0.26). Thus, the more-than-additive response was
elicited at a 100-fold lower fenpropathrin concentration and the amount of L-glutamate
release was enhanced 1.2-fold compared to synaptosomes treated at the 1:1,000 mixture
without ClTx. These findings were not surprising since NPPB and ClTx target the same
chloride channels (VGClC and CaClC).
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CHAPTER 5

SUMMARY AND FUTURE DIRECTIONS

Thus far, our findings have implicated the importance of chloride channels in rat
brain synaptosomes in the acute neurotoxicity response of pyrethroids. Since NPPB and
ClTx are known inhibitors of ClC-2 VGClCs and CaClCs and have been shown to
enhance L-glutamate release, we propose that these channels are present in our
synaptosomal preparations and are modified by pyrethroids.

PTX did not elicit a

concentration-dependent response. It is not clear whether GABAAClC are absent in our
synaptosome preparation or if the level of expression is so low that our assay is not
sensitive enough to detect any increase in L-glutamate release due to blockage of these
channels.
There are at least two mechanisms by which pyrethroids are capable of eliciting
increased L-glutamate release from presynaptic nerve terminals that involve blockage of
the two chloride channels. In the first model, deltamethrin initially targets VGSCs and
causes synaptolemma depolarization due to an influx of sodium ions (Fig. 11). VGCCs
in active release zones activate in response to membrane depolarization and calcium
influx is prolonged due to modification by deltamethrin (Symington, S.B. 2007b). At this
time, the membrane potential has become significantly more positive than the ECl, and
under normal circumstances, VGClCs activate allowing negative charge to flux into the
synaptosome (hyperpolarization) and return the membrane potential back to RMP. In the
presence of a pyrethroid that blocks VGClCs, however, the hyperpolarizing
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VGSC-∆

Na+
Cl-

Presynaptic
Nerve Terminal

Synaptic vesicle

VGClC-∆

Hyperpolarizing
rectification

Cl-

VGClC

Membrane
depolarization

Ca2+

Glu
VGCC-∆

Figure 11: Mechanism by which L-glutamate release from presynaptic nerve terminals is
increased by the presence of deltamethrin. An open triangle (∆) indicates that respective
channel has been modified by deltamethrin.
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rectification of VGClCs cannot take place and the membrane remains depolarized. The
subsequent increase in localized calcium influx at active release zones allow synaptic
vesicles containing neurotransmitter to fuse with the presynaptic release machinery and
release neurotransmitters into the synaptic cleft. Neurotransmitter release is prolonged
and results in a more-than-additive response seen with certain binary mixtures of
pyrethroids.
A second mechanism by which pyrethroids may elicit a more-than-additive
response on L-glutamate release is by suppressing the activity of CaClCs, which are
indirectly regulated by the metabotropic L-glutamate receptor (mGluR), part of the Gprotein coupled receptor (GPCR) (Fig. 13).
Initially, the binding of released L-glutamate to the mGluRs associated with the
synaptolemma of the presynaptic nerve terminal results in a conformational change of the
GPCR activating the G-protein by binding GTP to the Gα subunit. Upon activation, Gα
and Gβγ subunit disassociation (due to activation of the complex by GTP) allows Gβγ to
bind directly to two regions on the VGCC, the α1 subunit interaction domain (AID) and a
sequence downstream in domain II (D2), ultimately inhibiting VGCC activity (De
Waard, M. 1997; Symington, S.B. 1999) and decreasing neurotransmitter release. GTP is
then hydrolyzed to GDP since this subunit possesses GTPase activity, allowing Gα to
eventually reassociate with the Gβγ complex.
The Gβγ complex has also been implicated in the upregulation of PLC activity, as
demonstrated by Symington et al. in Paramecium tetraurelia (Symington, S.B. 1999).
PLC activity in calcium channel containing vesicles was further increased in the presence
of deltamethrin (1 x 10-7 M), suggesting that deltamethrin enhances the Gβγ
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Figure 12: Mechanism by which intracellular signaling pathways increase Lglutamate release from presynaptic nerve terminals in the presence of deltamethrin.
An open triangle (∆) indicates that respective channel has been modified by
deltamethrin.
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activation of PLC (Symington, S.B. 1999) and these findings are consistent with the
second mechanism by which pyrethroids may elicit a more-than-additive response on Lglutamate release.
Upon sustained stimulation of GPCR by excess L-glutamate, however, the Gprotein complex can stimulate phospholipase C (PLC) to hydrolyze phosphatidyl
insositol-biphosphate (PIP2) (Iglesias, I. 2007) to yield diacylglycerol (DAG) and inositol
triphosphate (IP3). IP3 diffuses through the cytosol and promotes release of calcium from
intracellular stores in the endoplasmic reticulum (ER). The mobilization of intracellular
calcium in the presence of DAG then activates PKC (Cuellar, J.C. 2005). Upon PKC
activation, VGCCs in the active release zone of presynaptic nerve terminals become
phosphorylated and allow an increase influx of extracellular calcium, which in turn
activates neurotransmitter release. The IP3-dependent calcium released from intracellular
stores is also available to activate CaClCs, allowing chloride ions to flux out, which
depolarizes the membrane. If the membrane potential becomes more positive than the
threshold values for VGSC and VGCC activation, these channels become inactivated,
ultimately contributing to presynaptic inhibition (Graham, B. 1994; Meir, A. 1999). If
CaClCs are blocked by pyrethroids, however, the synaptolemma will not be depolarized
and VGSC and VGCC will remain activated allowing the increased release of Lglutamate, contributing to the more-than-additive response as seen with our pyrethroid
binary mixtures.
Overall, the implications from this research suggest that the more-than-additive
response binary mixtures previously determined by Frisbie (Frisbie, R.K. 2006)
(deltamethrin plus S-bioallethrin, deltamethrin plus β-cyfluthrin, deltamethrin plus
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cypermethrin, and deltamethrin plus fenpropathrin) may present a cumulative risk to
mammals since three of the four elicited the more-than-additive response at pyrethroid
concentrations less than those needed to elicit salivation and choreoathetosis (Rickard, J.
and Brodie, M.E. 1985). Rickard and Brodie determined that 0.118 nmole deltamethrin /
g brain tissue were needed to elicit salivation whereas 0.379 nmole deltamethrin / g brain
tissue were needed to elicit choreoathetosis in rats. In the binary mixtures of pyrethroids
tested, only deltamethrin plus S-bioallethrin exceeded these levels. Thus deltamethrin in
binary mixture with β-cyfluthrin, cypermethrin, and fenpropathrin, however, are
toxicologically relevant since these mixtures elicited the more-than-additive response at
concentrations below the levels observed to elicit salivation and choreoathetosis and their
actions likely contribute to the production of the neurotoxic symptoms of poisoning.
Our findings suggest that ClC-2 and/or CaClCs are potential target sites for
certain pyrethroids and likely are important in pyrethroid neurotoxicity. To determine if
one or both of these channels are modified by pyrethroids, the next line of investigation
would entail heterologous expression of these channels from rat brain in Xenopus laevis
oocytes using two-electrode voltage clamp to monitor chloride conductance in the
presence and absence of selected pyrethroids. Since ClC-2 rectify membrane potential, it
would be expected that depolarizing the oocyte during a voltage-clamp experiment
(raising the membrane potential above ECl) would cause an inward flux of chloride ions.
In the presence of our most potent pyrethroid, deltamethrin, it would be expected that
chloride channel activity would be inhibited and peak current should be abolished. In the
presence of a pyrethroid that does not modify VGClCs (e.g. tefluthrin), peak current
should not be affected.
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Heterologous expression of CaClCs would be expected to cause an outward flux
of ions to resulting in a depolarization of the presynaptic nerve terminal and ultimately
inactivating endogenous VGSCs and VGCCs. In the presence of deltamethrin, these
channels would not inactivate VGSCs and VGCCs, resulting in a sustained depolarization
of the membrane. Tefluthrin should not affect the gating kinetics of CaClC. Findings
from these experiments would be expected to reveal whether or not certain pyrethroids
modify these channels directly and if they could contribute to the more-than-additive
response on L-glutamate release seen using our synaptosomal preparations.
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APPENDIX A
CHLORIDE CHANNEL ANTAGONIST STRUCTURES
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Appendix A. The structural configurations of the chloride channel blockers used in this
study.
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APPENDIX B
PYRETHROID STRUCTURES
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